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Coronary artery disease (CAD) is a condition that decreases the flow of blood through the coronary arteries 
around the heart (Merriam-Webster Incorporated, 2019) that can lead to a heart attack (Yayan, 2014). It 
is the leading cause of death worldwide (Nowbar et al., 2019) and there are several risk factors that 
contribute to its development (Fuster and Kelly, 2010). Non-modifiable risk factors are age, gender and 
ethnicity/race and family history, while modifiable risk factors include hypertension, 
hypercholesterolemia, obesity and sedentary lifestyle, diabetes mellitus and smoking (Jaggi & Kearns, 
2012; Winham et al., 2014; Yayan, 2014; Papadakis & McPhee, 2016; Nowbar et al., 2019). 
While it is reported that CAD in Sub-Saharan Africa is rare (Forouzanfar et al., 2012) reports from the 
World Health Organization (WHO) African region suggest that non-communicable diseases in this region 
are on the rise (World Health Organization African Regional Office, 2018). However, epidemiological 
data of this region is scanty. The only major studies available for South Africa (SA) are the Heart of 
Soweto study and the work of Prof. Bongani M Mayosi which report that the prevalence of modifiable 
risk factors for CAD is high and rising, especially in the black African population (Sliwa et al., 2008; 
Tibazarwa et al., 2009; Mayosi et al., 2009; Pretorius et al., 2011; Mayosi et al., 2012; Mayosi & Benatar, 
2014), emphasizing the need for epidemiological studies into this phenomenon (Stewart et al., 2006; Sliwa 
& Mocumbi, 2010; Senkubuge & Mayosi, 2013). 
No CAD data exists for central SA. The profile of patients of patients presenting with CAD at Universitas 
Academic Hospital (UAH) have not been documented in the past. 
Aim 
To document the profile of public sector patients who had confirmed CAD (on coronary angiography) in 
central SA and determine if there was a change over twenty years. 
Methods 
This was a retrospective single-centre observational cohort comparing two time periods, twenty years 
apart, conducted at UAH, Bloemfontein. The main inclusion criterion was confirmed atherosclerotic CAD 
as reported on coronary angiography. Medical records/data of all public sector patients who underwent 
coronary angiography during 1994 and 2014 were evaluated. Demographic data, which forms part of the 
non-modifiable risk factors for CAD, and other relevant clinical information was recorded. 
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Results 
Acute coronary syndrome (ACS) increased over the study period (p<0,0001) and this can be attributed to 
a notable increase in both Non-ST-Elevation Myocardial Infarction (NSTEMI) (p<0,0001) and ST-
Elevation Myocardial Infarction (STEMI) (p<0,0001). Unstable angina decreased significantly over the 
study period (p<0,0001). There was a significant increase in the number of African patients who 
experienced STEMI over the study period (p<0,0001) and there was a substantial decrease in Caucasian 
patients who had ACS (p=0,0015). While NSTEMI increased significantly in Caucasian patients 
(p<0,0001), unstable angina in this group decreased significantly (p<0,0001). 
Females with ACS presented 4 years earlier in 2014 than those in 1994 (1994 median age = 66 years vs. 
2014 median age = 62 years) (p=0,0031, 95% CI 1,3941; 6,7202). This trend was predominantly 
demonstrated in Caucasian females only (1994 median age = 66 years vs. 2014 median age = 62 years; 
p=0,04811, 95% CI 0,0276; 6,5743). The age of females with STEMI decreased significantly from 1994 
(median age 69 years) to 2014 (median age 60 years) (p=0,0119; 95% CI 1,4195; 10,8305). Females with 
unstable angina were six years younger in 2014 (median age 60 years) than in 1994 (median age 66 years) 
(p=0,0269, 95% CI 0,5800; 9,1978). Caucasian females with NSTEMI was markedly older in 2014 
(median age 66 years) than in 1994 (median age 50 years) (p<0,0001, 95% CI -19,7368; -12,8882), while 
those with STEMI became younger (1994 median age = 69 years vs. 2014 median age = 60 years, 
p=0,0269; 95% CI 0,9640; 14,6464). 
Conclusions 
There was an epidemiological change in public sector patients who had confirmed CAD in central SA 
with CAD increasing in patients of African and mixed ethnicity. ACS rose significantly over time with 
females presenting at a significantly younger age. STEMI became the most important presenting condition 
in patients of African ethnicity whilst NSTEMI increased in Caucasian patients. These findings have 
important implications for central SA public sector patients presenting with chest pain – the risk of STEMI 
in patients of African ethnicity is increasing and should not be ignored by clinicians. 
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An acute ischemic insult to the myocardium resulting from sudden 
reduction in coronary blood flow. ECG findings categorizes patients into 
two major subdivision of major diagnostic and therapeutic consequences: 
ST-elevation ACS (generally reflects an acute total coronary occlusion) or 
non-ST elevation ACS (Patients with acute chest pain but no persistent ST-
segment elevation). Non-ST elevation ACS is further classified either 
unstable angina or NSTEMI (Ahmad & Ali, 2019). 
Angina pectoris 
Severe constricting pain or sensation of pressure in the chest, often radiating 
from the precordium to a shoulder (usually left) and down the arm, resulting 
from ischemia of the heart muscle usually caused by coronary disease 
(Stedman’s Online, 2019). 
Artery 
A relatively thick-walled, muscular, pulsating blood vessel conveying 
blood away from the heart. With the exception of the pulmonary and 
umbilical arteries, the arteries contain red or oxygenated blood (Stedman’s 
Online, 2019). 
Atheroma 
The lipid deposits in the intima of arteries, producing a yellow swelling on 
the endothelial surface; a characteristic of atherosclerosis (Stedman’s 
Online, 2019). 
Atherosclerosis 
Hardening of the arteries characterized by irregularly distributed lipid 
deposits in the intima of large and medium-sized arteries, causing 
narrowing of arterial lumens and proceeding eventually to fibrosis and 
calcification. Lesions are usually focal and progress slowly and 
intermittently. Limitation of blood flow accounts for most clinical 
manifestations, which vary with the distribution and severity of lesions 
(Stedman’s Online, 2019). 
Cardiac catheterization 
Process whereby a thin flexible catheter is introduced into an artery and 
advanced into the heart for diagnosis or therapy (Stedman’s Online, 2019). 







Any structural or functional disease of heart muscle that is marked 
especially by enlargement of the heart, by hypertrophy of cardiac muscle, 
or by rigidity and loss of flexibility of the heart walls and that may be 
idiopathic or attributable to a specific cause (such as heart valve disease, 




This refers to the whole circulatory system: the heart, the systemic 
circulation (the arteries and veins of the body) and the pulmonary 
circulation (the arteries and veins of the lungs). Blood circulates throughout 
the cardiovascular system, bringing oxygen and nutrients to the tissues and 
removing carbon dioxide and other waste products (Marcovitch, 2018). 
Cholesterol 
A lipid that is an important constituent of body cells and is widely 
distributed throughout the body. It is especially abundant in the brain, 
nervous tissue, adrenal glands and skin. A high blood-cholesterol level – 
that is, one over 6 mmol per litre or 238 mg per 100 ml – is undesirable as 
there appears to be a correlation between a high blood cholesterol and 
atheroma, the form of arterial degenerative disease associated with coronary 
thrombosis and high blood pressure. Cholesterol exists in three forms in the 
blood: high-density lipoproteins (HDL) which are believed to protect 
against arterial disease; a low-density version (LDL); and a very low-
density type (VLDL) – these latter two being risk factors (Marcovitch, 
2018). 
Coronary 
A term applied to any structure in the body encircling an organ in the 
manner of a crown. Most commonly it is used in reference to the coronary 
arteries, through which blood is delivered to the muscle of the heart 
(Marcovitch, 2018). 
Coronary angiography 
Imaging of the circulation of the myocardium by injection of contrast 
medium, usually by selective catheterization of each coronary artery 
(Stedman’s Online, 2019). 
Coronary artery bypass 
graft (CABG) 
A surgical procedure in which damaged sections of the coronary arteries are 
replaced with new articular of venous graftings to increase rate of cardiac 
blood flow (Stedman’s Online, 2019). 
Electrocardiogram 
(ECG) 
Graphic record of the heart's integrated action currents obtained with the 
electrocardiograph displayed as voltage changes over time (Stedman’s 
Online, 2019). 




The study of disease as it affects groups of people. Originating in the study 
of epidemics of diseases like cholera, plague and smallpox, epidemiology 
is an important discipline which contributes to the control not only of 
infectious diseases but also of conditions such as heart disease and cancer. 
Their distributions in populations can provide important pointers to possible 
causes (Marcovitch, 2018). 
Ethnicity/ethnic group 
A social group characterized by a distinctive social and cultural tradition 
maintained from generation to generation, a common history and origin, 
and a sense of identification with the group; members have distinctive 
features in their way of life, shared experiences, and often a common 
genetic heritage; these features may be reflected in their experience of 
health and disease (Stedman’s Online, 2019). 
Heart 
A hollow muscular pump with four cavities, each provided at its outlet with 
a valve, whose function is to maintain the circulation of the blood. The two 
upper cavities are known as atria, and the two lower ones as ventricles 
(Marcovitch, 2018). 
Heart failure 
Inadequacy of the heart so that as a pump it fails to maintain the circulation 
of blood, with the result that congestion and oedema develop in the tissues 
(Stedman’s Online, 2019). 
Ischemia 
Local loss of blood supply due to mechanical obstruction (mainly arterial 
narrowing or disruption) of the blood vessel (Stedman’s Online, 2019). 
Ischaemia develops if myocardial oxygen demand exceeds supply 
(Swanton & Banerjee, 2008). 
Ischemic 
cardiomyopathy 
Ischaemia and infarction with subsequent loss of contractility and 
remodelling of the heart (Lüscher, 2016). 
Myocardial infarction 
Infarction of a segment of heart muscle, usually due to occlusion of a 
coronary artery (Stedman’s Online, 2019). 
Non-communicable Not transmissible by direct contact (Merriam-Webster Incorporated, 2019). 
Non-Q-wave myocardial 
infarction 
Evidence of infarction in the absence of abnormal Q waves in any 
combination of leads I, aVL and VI to V6 and leads II and aVF (Montague 
et al., 1986). 






A type of myocardial infarction causing cardiomyocyte necrosis and death 
by a rise in serum troponin levels. The ECG may be normal or there may 
be transient ST-segment elevation, persistent or transient ST-segment 
depression, T-wave inversion, flat T waves or pseudo-normalization of T 
waves (Ahmad & Ali, 2019). 
Percutaneous coronary 
intervention (PCI) 
An invasive treatment for a stenosed (narrowed) coronary artery. A balloon-
tipped catheter is passed through artery of the heart that has developed 
stenosis. The balloon is aligned with the stenosed section and then inflated 
to dilate the coronary artery and allow the blood to flow more freely. A stent 




A minimally invasive surgical procedure for the treatment of coronary 
atherosclerosis. A balloon-tipped catheter is inserted percutaneously into 
the arterial circulation, advanced to the aortic root, and directed with a 
flexible guide wire to the site of coronary stenosis. Having been positioned 
within the narrowed arterial segment, the balloon is inflated so as to stretch 
the lumen, fracture the obstructing plaque, or both (Stedman’s Online, 
2019). 
Retrospective 
Relating to or being a study (as of a disease) that starts with the present 
condition of a population of individuals and collects data about their past 
history to explain their present condition (Merriam-Webster Incorporated, 
2019). 
Stable angina 
Angina induced by effort and relieved by rest. It does not increase in 
frequency or severity, and is predictable in nature (Swanton & Banerjee, 
2008). 
Statin 
A lipid-lowering drug used to treat primary hypercholesterolaemia – a 
condition in which the concentrations of lipoproteins in the blood plasma 
are raised, increasing the likelihood of affected individuals developing 
coronary heart disease (Marcovitch, 2018). 








Acute myocardial injury (heart attack) detected by abnormal cardiac 
biomarkers in the setting of evidence of acute myocardial ischemia and with 
detection of a rise and/or fall of cardiac Troponin values together with 
symptoms of myocardial ischemia, new ischemic ECG changes (new ST-
segment elevations in 2 contiguous leads or new bundle branch blocks with 
ischemic repolarization patterns), development of pathological Q waves, or 
imaging evidence of new loss of viable myocardium or new regional wall 
motion abnormality in a pattern consistent with an ischemic aetiology 
(Thygesen et al., 2018). 
Stent 
A widely used device with metal surfaces that are sometimes coated with a 
drug to prevent restenosis. It is used to maintain luminal patency 
(Stedman’s Online, 2019). 
Unstable angina 
Myocardial ischemia at rest or minimal exertion in the absence of 
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Chapter 1: Problem statement and rationale 
1.1. Introduction 
Coronary artery disease (CAD) is a condition that decreases the flow of blood through the coronary 
arteries around the heart (Merriam-Webster Incorporated, 2019) that can lead to ischemic heart disease 
(IHD) or a myocardial infarction (heart attack) (Yayan, 2014). It is the leading cause of death 
worldwide (Nowbar et al., 2019), killing about 3.8 million men and 3.4 million women each year 
(Clarify Registry Investigators, 2018). Worldwide it is estimated to be prevalent in approximately 
153.5 million people (with higher prevalence in males than females) (Benjamin et al., 2019). Put in 
another way: In adults, CAD causes about one-third of all deaths (Sanchis-Gomar et al., 2016). 
There are several, well-known risk factors that contribute to the development of CAD in adults (Fuster 
and Kelly, 2010). Modifiable risk factors include hypertension, hypercholesterolemia, obesity and 
sedentary lifestyle, diabetes mellitus and smoking, while non-modifiable risk factors are age, gender 
and ethnicity/race and family history (Jaggi & Kearns, 2012; Winham et al., 2014; Yayan, 2014; 
Papadakis & McPhee, 2016; Nowbar et al., 2019). 
In developing countries such as India, Egypt and Pakistan, CAD is reported to be on the rise 
(Sriharibabu, 2016; Prabhakaran et al., 2018). This trend can also be seen in other developing countries. 
Between 1984 and 1999 Beijing’s coronary heart disease mortality rates increased by 27% in women 
and a staggering 50% in men (ages 35 to 74 years) (Critchley et al., 2004). In North Africa, Tunisia 
experienced increased CAD mortality rates of 11,8% in men (from 70 to 87 deaths per 100,000) and 
23,8% in women (from 28 to 41 deaths per 100,000) from 1997 to 2009 (Saidi et al., 2013). 
Forouzanfar et al. (2012) reported that IHD in the southern regions of Africa is quite rare, but reports 
from the World Health Organization (WHO) African region suggests that non-communicable diseases 
in Sub-Saharan Africa, as well as the costs related to their treatment, are on the rise (World Health 
Organization African Regional Office, 2018). CAD is predicted to be one of the leading causes of 
morbidity and mortality by 2020 for most developing nations (Celermajer et al., 2012). The rise in 
CAD in African populations is generally ascribed to the increase of modifiable risk factors for CAD 
(Yusuf et al., 2001a; Gersh et al., 2010; Nowbar et al., 2019; Benjamin et al., 2019). There is, however, 
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a significant problem: epidemiological data, of any type, is almost totally absent in the southern regions 
of Africa. Most of this regions’ estimates comes from South Africa (SA) alone (Moran et al., 2012). 
The only major studies available for SA are the Heart of Soweto study and the work of Prof. Bongani 
M Mayosi. These studies report that the prevalence of modifiable risk factors for CAD is high and 
rising, especially in the black African population (Sliwa et al., 2008; Tibazarwa et al., 2009; Mayosi 
et al., 2009; Stewart et al., 2011; Mayosi et al., 2012; Mayosi & Benatar, 2014). Therefore, 
emphasizing the need for epidemiological studies into this phenomenon (Stewart et al., 2006; Sliwa & 
Mocumbi, 2010; Senkubuge & Mayosi, 2013). 
While reviewing SA literature it was found that there is a significant lack of data from central SA 
specifically. The profile of patients who had confirmed CAD at UAH have not been documented in 
the past. There is a limited number of publications on this subject in central SA, especially in the Free 
State. By identifying demographic over the past two decades, this study aimed to begin the process of 
filling this deficit. 
© Central University of Technology, Free State
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1.2. Research question 
What is the profile and was there a change in the profile of patients who had confirmed CAD on 
coronary angiography at UAH in 2014 as compared to 1994? 
1.3. Aim 
The aim of this study was to determine what the profile was and if there was a change in the profile of 
patients who had confirmed CAD on coronary angiography at UAH in 2014 as compared to 1994. 
1.4. Objectives 
 Establish the total number of patients that underwent coronary angiography in 1994 and 2014 
at Universitas Academic Hospital. 
 Analyse the age group, gender, and ethnicity of patients that underwent coronary angiography 
in 1994 and 2014 at UAH. 
 Determine the number of patients that had healthy coronary arteries among patients that 
underwent coronary angiography in 1994 and 2014 at UAH. 
 Determine the percentage of patients that had diseased coronary arteries among patients that 
underwent coronary angiography in 1994 and 2014 at UAH. 
 Compare and contrast the non-modifiable risk factors and the treatment modalities of patients 
that underwent coronary angiography in 1994 and 2014 at UAH. 
 Quantify the number of patients that underwent CABG after coronary angiography in 1994 and 
2014 at UAH. 
 Identify non-modifiable risk factor trends between patients that underwent coronary 
angiography in 1994 and 2014 at UAH. 
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Chapter 2: Literature review 
2.1. What is coronary artery disease? 
Coronary artery disease (CAD) is a condition that decreases the flow of blood through the coronary 
arteries around the heart, and is mainly caused by atherosclerosis (Merriam-Webster Incorporated, 
2019). Atherosclerosis is the chronic inflammation of arteries (Nabel & Braunwald, 2012) that results 
from damage to the endothelial cells of the blood vessels (Hall, 2011), in this case the coronary arteries 
around the heart. Adults often develop some coronary atherosclerosis in their early years of life (Gould 
et al., 2013) but it usually takes decades for the disease to progress to a stage where patients experience 
any symptoms (Sanchis-Gomar et al., 2016). Cardiovascular ischemic events often do not appear until 
men are in their fifties and women are in their sixties (Sayols-Baixeras et al., 2014). More recently it 
was shown to take even longer: the average age for a first heart attack is 65,6 years for males and 72 
years for females (Benjamin et al., 2019). 
The disease begins when large quantities of cholesterol are deposited underneath the endothelium of 
an artery (Hall, 2011) thereby causing thickening of the intramural layer of the artery. This cholesterol 
deposition and intramural thickening results in a fatty streak developing throughout the artery. Plaques, 
also known as atheromas, start to develop in “patches” at many points throughout the artery. These 
plaques consist of inflammatory cells, smooth muscle cells, fibrous connective tissue cells and lipids 
(Aziz & Yadav, 2016). These plaques can be obstructive or non-obstructive. Obstructive plaques lead 
to impaired blood flow through the artery as seen in Figure 2-1 (Maddox et al., 2014) causing the 
muscle to suffer damage from lack of oxygen and nutrients. 
© Central University of Technology, Free State
M.A.S.E. Bester
M.HSc Clinical Technology Dissertation
5 
Figure 2-1: Comparison between normal artery and atherosclerotic artery. Adapted from Reddy & 
Grubb, 2018. 
As atherosclerosis progresses over the course of decades, there is an ever-increasing reduction in the 
diameter of the artery and a resultant impairment of blood flow to the heart muscle. This leads to 
ischemic cardiomyopathy (heart failure) or, ultimately, a myocardial infarction (heart attack) due to a 
complete blockage of the blood vessel (Yayan, 2014). At certain points in the artery the atherosclerotic 
plaque can rupture and come into direct contact with the flowing blood. Platelets adhere to the site of 
rupture, fibrin is deposited and red blood cells are trapped leading to thrombus formation inside the 
vessel. The thrombus can occlude the vessel at the site of rupture, or break off and travel to a more 
distal (farther) part of the artery and occlude it at that point (Hall, 2011). This process is demonstrated 
in Figure 2-2. 
Coronary occlusion causes prolonged ischemia of the myocardial cells, leading to myocardial cell 
death in as little as twenty minutes (Vojáček et al., 2013). If the blood flow is interrupted on a 
temporary basis it causes unstable angina (chest pain) and if it is interrupted on a permanent basis it 
causes a myocardial infarction (heart attack) (Nabel & Braunwald, 2012). Most myocardial infarctions 
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are caused by rupture of an unstable atherosclerotic plaque that then causes thrombosis and total 
occlusion of a coronary artery (Khamis et al., 2016). In America it is estimated that there is a 
myocardial infarction every forty seconds (Benjamin et al., 2019). 
Figure 2-2: Progression of atherosclerosis. Adapted from Groenendyk & Mehta, 2018. 
2.2. Symptoms of CAD 
As described by Hall (2011), the main functions of the circulatory system i.e. the heart and blood 
vessels, are: 
Transport of nutrients, waste products and hormones to and from body tissues, and 
The general maintenance of an appropriate environment in all the tissue fluids of the body to 
ensure optimal survival and functioning of the cells. 
If the circulation of blood in the coronary arteries is impaired a mismatch between oxygen demand 
and supply occurs which leads to chest pain and, possibly, heart failure: This is referred to as ischemic 
heart disease (IHD) or coronary insufficiency (Merriam-Webster Incorporated, 2019). IHD results 
from CAD. The symptoms of CAD can be classified into two groups: Stable angina, and acute coronary 
syndrome (ACS). ACS is a subcategory of CAD (Sanchis-Gomar et al., 2016) and the collective term 
used to describe unstable angina, Non-ST-segment Elevation Myocardial Infarction (NSTEMI), and 
ST-segment Elevation Myocardial Infarction (STEMI) (Yayan, 2014). 
ST-segment elevation, or T-wave changes, are the earliest manifestations of myocardial ischemia on 
the electrocardiogram (ECG) (Vojáček et al., 2013). During a myocardial infarction myocyte cell death 
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occurs and certain biomarker proteins are released from inside the cells. These biomarkers include 
myoglobin, creatine-kinase MB, C-reactive protein and cardiac troponin (Fathil et al., 2015). Cardiac 
troponin (Troponin T and I) is a commonly-used marker of cardiac damage because it is highly specific 
and sensitive to heart cells (Garg et al., 2017). In short, the difference between STEMI and NSTEMI 
is as follows: 
 During a STEMI the ECG shows elevation of the ST-segment, and blood tests are positive for 
cardiac markers. 
 During a NSTEMI the ECG may show signs of ischemia such as ST-depression or T-wave 
changes, or it may be normal, while blood tests are positive for cardiac biomarkers (Daga et 
al., 2011). 
Angina pectoris is chest pain that is pressure-like in nature (Moran et al., 2012) that occurs as a result 
of decreased myocardial blood flow, or subsequent myocardial cell death (Shah & Sikkel, 2013). In 
American adults the overall presence of angina is 3,6% in adults older than the age of 20 (Benjamin et 
al., 2019). Angina pectoris can be stable, meaning that it is induced by exertion, physical or mental 
stress; or unstable, meaning that it occurs at rest (Forouzanfar et al., 2012). Angina pectoris and the 
subsequent classification of ACS are depicted in Figure 2-3. 
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Figure 2-3: Angina pectoris and classification of acute coronary syndrome. Adapted from Pleister et 
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2.3. Risk factors associated with CAD 
There are several, well-known risk factors that contribute to the development of CAD in adults (Nowbar 
et al., 2019) (Table 2-1). Estimates show that 47% of Americans have at least one key risk factor for 
CAD (Fryar et al., 2012; Benjamin et al., 2019). In SA these risk factors have been emerging in both 
rural as well as urban communities for several decades (Mayosi et al., 2009; Pretorius et al., 2011). 
Modifiable risk factors are those which the individual can change and therefore has control over; non-
modifiable risk factors are those over which the individual has no control. 
For this study emphasis was placed on the non-modifiable risk factors as outlined in Table 2-1. 
Table 2-1: Risk factors for CAD. Adapted from Jaggi & Kearns, 2012; Yayan, 2014; Winham et al., 
2014 and Nowbar et al., 2019. 
Modifiable Non-modifiable 
Hypertension Age (Males >45 years and females >55 years) 
Hypercholesterolemia Gender 
Obesity (coupled with sedentary lifestyle) Ethnicity/race  
Diabetes Mellitus Family history of CAD (genetic predisposition) 
Smoking 
2.3.1. Non-modifiable risk factors 
2.3.1.1. Age 
Merriam-Webster Incorporated (2018) defines age as “an individual's development measured in terms 
of years” A long lifespan is a non-modifiable risk factor that can increase the burden of cardiovascular 
disease (Nabel and Braunwald, 2012) because it causes loss of function in multiple systems of the body 
(Papadakis and McPhee, 2016). This is evident in the fact that the incidence of CAD increases with age, 
in both men and women (Keller and Howlett, 2016). The reason for this is that endothelial function 
progressively deteriorates the older a person gets and this causes increased stiffness of blood vessels 
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(Harvey, Montezano and Touyz, 2015). From 2005 to 2015, in both high and low income countries, the 
mortality rates of CAD increased with age (Nowbar et al., 2019). 
Not only is age itself a risk factor for development of CAD, but the traditional risk factors are also 
independently associated with ageing (Yayan, 2014). This is observed in people over 60 years of age 
who develop a slight increase in systolic blood pressure (Hall, 2011), and in people who develop 
markedly increased amounts of epicardial adipose tissue as they age (Silaghi et al., 2008). 
In Figure 2-4 one can see that the death rates for non-communicable diseases in SA gradually increases 
with age. It is predicted that an estimated 14.8% of the SA population will be older than 60 years of age 
in 2050 (United Nations Population Fund (UNFPA), 2012). This is worrisome because an ageing 
population might mean a higher burden of CAD and increased healthcare cost. 
 
Figure 2-4: Age-specific death rates for non-communicable diseases in South Africa from 1997 to 
2007, by age group. Adapted from Bradshaw et al., 2010.  
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2.3.1.2. Gender 
It has long been debated whether a person’s gender predisposes them to higher risk for the development 
of CAD. It is known that CAD occurs more frequently in men than in women of all ages (Benjamin et 
al., 2019). Due to a particular combination of sex chromosomes as well as different levels of sex 
hormones between men and women there is a marked difference between males and females (Winham 
et al., 2014; Duda-Pyszny et al., 2018). Even the widths of the QRS complex (on the ECG) have been 
found to be different between men and women (Hnatkova et al., 2016). Therefore, it is only logical to 
deduce that there are differences in CAD between men and women. 
Even though the systemic risk factors for CAD are very similar between men and women, the impact of 
the various risk factors on men and women are different (Yahagi et al., 2015). For example, it has been 
suggested that higher levels of testosterone can lead to reduced levels of atherosclerosis in men (Oskui 
et al., 2013). Men also tend to have a higher risk for obstructive CAD, while it is more likely caused by 
microvascular disease in women (Gulati et al., 2012). Another example is that women who suffer from 
diabetes are subject to a 40% greater risk of having a coronary heart disease incident than men with the 
same condition (Peters et al., 2014); additionally, women also have a much higher risk of losing more 
years of life after they had a myocardial infarction (Bucholz et al., 2015). 
Arshad and Pasha (2013) carried out a study that analysed the variations in risk factor prevalence among 
men and women. Although they only studied hypertensive patients, they found that obesity was more 
common among women while smoking was more common among men. When looking at cholesterol, 
the “bad” low-density lipoprotein (LDL) cholesterol is lower in women than it is in men, until 50 years 
of age. After this age LDL gradually increases with age and this offers an explanation for the higher 
CAD incidence in older women (Yahagi et al., 2015). This is in agreement with the finding that women 
usually have better risk factor profiles when they are younger, but the opposite occurs when they age 
(Duda-Pyszny et al., 2018). 
There are various explanations for differences in CAD between men and women, including different 
lifestyles and diets, different behaviours and differing attitudes with regards to prevention among men 
and women (Kautzky-Willer et al., 2016). No matter what the cause of the difference, it is important to 
keep in mind that there are special gender-related factors, such as pregnancy and menopause in women 
(Khamis et al., 2016; Benjamin et al., 2019) as well as the presence of oestrogen and other female 
reproductive hormones (Duda-Pyszny et al., 2018) that cause differences in CAD. Therefore, gender 
© Central University of Technology, Free State
M.A.S.E. Bester 




should be considered as a risk factor on its own in order to develop a targeted approach for the optimal 
reduction of CAD among males and females. 
2.3.1.3. Ethnicity/Race 
Ethnicity/race has been shown to influence the development of CAD (Winham et al., 2014). CAD has 
been a significant problem among certain SA population groups for a long time (Seedat et al., 1990). It 
is known that hypercholesterolemia occurs in about one of every 200 white Afrikaners (Steyn et al., 
1996) and that the Indians of SA are more prone to IHD because they are more resistant to insulin than 
other population groups (Mayosi et al., 2009). Among black South Africans the leading risk factors for 
CAD are hypertension (40%), smoking (40%) and obesity (39%) (Brand et al., 2013). 
In spite of these high risk factor percentages among black individuals, Mayosi et al. (2009) report that 
IHD still only accounts for about 10% of all heart disease, which makes it fairly uncommon. This is 
evident in the fact that white people in SA have a higher rate of clinically documented myocardial 
infarction than black people (Zhang et al., 2016). One possible explanation might be that black people 
metabolize homocysteine more effectively than white people (Ubbink et al., 1995). 
In spite of CAD being reported as rare among African patients, the ACCESS (Acute Coronary Events – 
a Multinational Survey of Current Management Strategies) registry showed that (from January 2007 to 
January 2008) 10,7% of ACS patients in SA were of mixed ancestry and 5,9% were African (Schamroth, 
2012). This seem to indicate that there is an upward trend in African patients with ACS and thus CAD. 
Several physicians agree that the race of a patient is a very important factor in understanding disease risk 
and for the implementation of effective treatment strategies (Snipes et al., 2011). The differences among 
different population groups, i.e. racial and ethnic differences, should be taken into consideration when 
undertaking research (Karter, 2003), as this will lead to better understanding of the different 
pathophysiology mechanisms (in order to target treatment accordingly); it will also help minimise 
healthcare disparities among different racial groups (Taylor et al., 2005). 
2.3.1.4. Family history of familial hypercholesterolemia or CAD 
Familial hypercholesterolemia is an inherited, or genetic, condition that leads to increased levels of LDL 
cholesterol which then increases the risk of early cardiovascular disease (Kandoria et al., 2017). Kulkarni 
(2015) found that a family history of early CAD is also a risk factor for developing CAD and actually 
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lowers the age of diagnosis. This is especially true if one has a first-degree relative who is affected by 
cardiovascular disease, the risk thereof being increased by 60% to 75%, as compared to the presence of 
cardiovascular disease in only a sibling, which typically represents a risk of 40% (Kolber & Scrimshaw, 
2014). According to the Framingham Heart Study a family history of premature CAD should be 
considered as an independent risk factor for CAD when there is a diagnosis of CAD of a first degree 
relative at <65 years in men and <55 years in women (Dai et al., 2016). 
Familial hypercholesterolemia among white Afrikaans-speaking communities in the South-Western 
Cape has been reported at about 1:87 (Jooste et al., 1986). A more recent study estimated the prevalence 
of familial hypercholesterolemia at the even higher rate of 1:72 (Steyn et al., 1996). In Johannesburg 1:5 
patients with hypercholesterolemia had familial hypercholesterolemia (Seftel et al., 1980). A similar 
prevalence of 1:4 was found a few years later, even though the study only analysed patients undergoing 
CABG (Seftel et al., 1987). In the same year 1:10 young Afrikaners who had myocardial infarctions 
were found to have familial hypercholesterolemia (Wyndham et al., 1987). In spite of these findings, 
Pedoe (1980) argued that genetics should not be blamed for the high prevalence of hypercholesterolemia, 
but rather the lifestyle of the specific group and the presence of other common modifiable risk factors. 
Even though the current statistics on this topic is scanty for SA the literature not only shows that familial 
hypercholesterolemia is a problem among white South Africans of Afrikaner descent (Delport, 2009), 
but that they are not the only group with a high prevalence of familial hypercholesterolemia. Due to 
founder effects in the SA population, Jewish South Africans of Lithuanian descent as well as Indian 
South Africans of Gujarati descent also have a higher prevalence of familial hypercholesterolemia 
(Blom, 2011). 
The prevalence of a family history of CAD is not known for the public sector of central SA. Due to the 
fact that patients with a family history of CAD are usually associated with a higher incidence of 
atherosclerosis than their counterparts (Cohen et al., 2014), the prevalence of a family history of 
hypercholesterolemia or CAD was also documented for this study. As a first step in generating a body 
of research, this retrospective data analysis lead to new information about CAD risk factors among the 
different population groups that underwent coronary angiography in central SA in 2014 as compared to 
1994, and demonstrated that there has been a change in the non-modifiable risk profile of these patients. 
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2.4. Prevention and treatment of CAD 
2.4.1. Modifiable risk factor control 
As early as 1948, during the Framingham Heart Study, the risk factors for CAD were identified and it 
was realized that this “lifestyle disease” could be prevented (Nabel & Braunwald, 2012). The most 
effective way of reducing adverse events due to CAD is by controlling the modifiable risk factors thereof 
(Gould et al., 2013). This is relatively manageable, and may be achieved by the adoption of a healthy, 
balanced diet, not smoking, daily physical activity and regular healthcare check-ups (Fuster & Kelly, 
2010). In their study of 55 685 participants, Khera et al. (2016) found that by simply following a healthy 
lifestyle the risk for CAD was substantially reduced. 
The prevention of CAD can also be attained by implementing public healthcare policies that has an 
impact on the population as a whole; examples are bans on smoking (Sayols-Baixeras et al., 2014) or 
the recent salt reduction policy that was implemented in SA in order to decrease hypertension (Watkins 
et al., 2016). 
2.4.2. Medical therapy 
The main medical approach to preventing CAD is statin drugs (Winham et al., 2014). These are lipid-
lowering drugs that are safe as well as effective (Blom, 2011). However, it should be noted that the risk 
of developing CAD is not completely eliminated by statin therapy (Nabel & Braunwald, 2012). The 
medical treatment of patients with CAD aims to reduce the progression of the disease, stabilize 
atherosclerotic plaques as well as cardiac function, and to improve patient symptoms (Holmes & 
Herrmann, 2018). Additional drugs that can be used for the treatment of CAD include Angiotensin-
Converting-Enzyme (ACE) inhibitors, beta-blockers and antiplatelet drugs such as aspirin and 
clopidogrel (Aziz & Yadav, 2016). 
2.4.3. Coronary revascularization procedures 
2.4.3.1. Cardiac Angiography 
Coronary angiography is performed to assess the severity of CAD (Gould et al., 2013) (Figure 2-5) and 
done according to standard catheterization laboratory procedure (Kosova & Ricciardi, 2017): For left 
heart catheterizations arterial vascular access is obtained either through the femoral or radial artery 
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(Figure 2-5A). The brachial artery can also be used but is a less common pathway to access the heart. A 
catheter is then advanced through the chosen access site, into the heart (Figure 2-5B). Usually the 
catheter is advanced all the way into the left ventricle, unless there is a contraindication for crossing the 
aortic valve (such as aortic stenosis). 
Once the catheter is in the left ventricle the internal cardiac pressure is recorded and contrast medium is 
injected under fluoroscopy. This is referred to as a ventriculogram and shows the contraction of the left 
ventricle. By measuring the chamber size during diastole as well as systole, the ejection fraction can be 
calculated. Wall motion abnormalities as well as the degree of mitral or aortic incompetence is also 
assessed during left ventriculography. 
Thereafter the catheter is withdrawn, over the aortic valve, back into the aorta. The pressure in the aorta 
is also recorded and any difference in pressure (pressure gradient) between the left ventricle and the 
aorta is recorded. Pressure gradients exist when aortic stenosis is present. 
Next the cardiologist engages the catheter in the ostium of the right and left coronary arteries, 
respectively. Although the sequence does not matter, some cardiologists prefer to start with the culprit 
artery that is causing the patient’s symptoms. Contrast medium is then injected into the artery and any 
flow-limiting lesions is identified under fluoroscopy (Figure 2-5C). 
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Figure 2-5: Angiogram procedure. Adapted from Kulathilake, 2017. 
2.4.3.2. Percutaneous Coronary Intervention (PCI) 
If there are obstructions present in the coronary circulation they can be opened in the catheterization 
laboratory (Nabel & Braunwald, 2012). This can be done by performing Percutaneous Transluminal 
Coronary Angioplasty (PTCA), or by placement of a stent. During PTCA a balloon-tipped catheter is 
advanced into the coronary artery, under radiographic guidance. The balloon is pushed through the 
obstruction until it straddles the partially occluded point. On inflation of the balloon the diseased artery 
is then stretched and blood flow through that point is increased. 
Although effective, PTCA is not always sufficient to open a vessel. In some cases it is necessary to place 
a stent in the artery. This is a small tube-like mesh structure designed to hold the artery open. Metals 
used to make stents include stainless steel, cobalt-chromium, gold, and tantalum. Polymers such as 
silicone and polyurethane can also be used. A stent is deployed in a similar manner as the PTCA balloon. 
Percutaneous coronary stent placement can be seen in Figure 2-6. The collective term for PTCA and 
stent placement in a coronary artery is PCI, or Percutaneous Coronary Intervention (Hall, 2011) For 
patients with one or two diseased coronary arteries that does not involve the proximal left anterior 
descending (LAD) artery, PCI is usually the preferred option (Holmes & Herrmann, 2018).  
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Figure 2-6: Coronary artery stent placement. Adapted from Reddy & Grubb, 2018. 
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2.4.3.3. Coronary artery bypass graft (CABG) surgery 
Coronary artery bypass graft (CABG) surgery is performed in patients who have severe coronary artery 
obstruction and who are not eligible for PCI. A graft vessel such as a leg vein is grafted onto the aorta 
and anastomosed onto the coronary artery distal to the obstruction. This is done to shunt or bypass blood 
around the obstruction and increase blood flow to the myocardium (Merriam-Webster Incorporated, 
2019). According to Rahman et al. (2017), the indications for CABG surgery include: 
 Triple vessel disease (with left ventricular ejection fraction <50% 
 Left main stem stenosis ≥50% 
 At least 70% stenosis in proximal Circumflex and LAD (also known as left main equivalent) 
 Where a large area of heart muscle is at risk with only single or double vessel disease 
 Debilitating angina despite optimal medical therapy 
 Subacute (>12 hours) unstable angina, STEMI or non-Q-wave myocardial infarction when 
ischemia is ongoing and cardiogenic shock is present despite maximal non-surgical therapy (such 
as intravenous thrombolytics and primary PCI). 
CABG surgery is preferred in patients who have two – or three vessel disease with left main disease and 
a SYNTAX (The SYNergy between percutaneous coronary intervention with TAXus and cardiac 
surgery trial) score greater than 32 (Mohr et al., 2013). The SYNTAX score is a tool used to determine 
which patients may benefit from CABG as opposed to PCI, by quantifying the extent of CAD (Yerokun 
et al., 2016). Patients who have intermediate or high SYNTAX scores (therefore complex CAD) usually 
benefit more from CABG, while patients with low SYNTAX scores (less complex CAD) can be treated 
with PCI, although repeat revascularization might be necessary for future treatment (Head et al., 2014). 
CABG should be combined with medical therapy to achieve better long term patient outcome (Velazquez 
et al., 2016). 
With this retrospective data analysis, the hope was to determine if there were any changes/improvements 
in the treatment modalities used to treat patients with CAD in 2014 as compared to 1994.  
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2.5. World figures on CAD 
According to the WHO, in 2015 there were a total of 56.4 million deaths worldwide. An astounding 15 
million (26.6%) of these deaths were caused by IHD (caused by CAD) and stroke (Figure 2-7) (World 
Health Organization, 2015). Even though mortality trends show that there might be some variability 
within broad geographic regions (Moran et al., 2012) and that mortality rates in Western countries have 
gradually declined over the last few decades, there are still 15.5 million people (20 years and older) who 
live with CAD in the United States of America alone. To put in it another way, CAD causes about one-
third of all deaths in adults (Sanchis-Gomar et al., 2016). 
Figure 2-7:  Top 10 causes of death globally 2015. Adapted from:  
http://www.who.int/mediacentre/factsheets/fs310/en/ 
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In metropolitan France acute myocardial infarction (STEMI + NSTEMI) cases rose from 15 per 104 (10 
000) in 2009 to 19.8 per 104 in 2014 for men and 6.3 per 104 to 8 per 104 for women (Pinaire et al., 
2019). Singapore saw in increase in STEMI incidence among Malay patients from 97 per 100,000 
population in 2007 to 114 per 100,000 population in 2014 (Zheng et al., 2019). Across Europe CAD 
accounts for 1.8 million (±45%) of the more than 4 million deaths caused by cardiovascular disease each 
year (Townsend et al., 2016). The Euro Heart Survey on Acute Coronary Syndromes (EHS-ACS-II) also 
reported a 5% rise (from 42% in 2000 to 47% in 2004) in STEMI among ACS patients (Mandelzweig 
et al., 2006). 
In India the situation is even more grave, with IHD and stroke together causing 83% of cardiovascular 
deaths, and with IHD being more predominant than stroke (Prabhakaran et al., 2016). From 2007 to 
2009, in Kerala (India), more patients presented with STEMI (37%) than NSTEMI (31%), or unstable 
angina (32%) (Mohanan et al., 2013). 
In other developing countries such as Egypt and Pakistan, CAD is also reported to be on the rise 
(Sriharibabu, 2016; Prabhakaran et al., 2018). There are also upward trends in other developing 
countries. Between 1984 and 1999 Beijing’s coronary heart disease mortality rates increased by 27% in 
women and a staggering 50% in men (ages 35 to 74 years) (Critchley et al., 2004). 
From these figures one can see that CAD is a major problem worldwide, but what does the situation look 
like in Africa? 
2.6. African figures of CAD 
Figure 2-8 indicates that IHD as a cause of death is by far much higher in North Africa and the Middle 
East, when compared to other regions of the world (Almahmeed et al., 2012). From 1997 to 2009 Tunisia 
experienced increased CAD mortality rates of 11,8% in men (from 70 to 87 deaths per 100,000) and 
23,8% in women (from 28 to 41 deaths per 100,000) (Saidi et al., 2013). 
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Figure 2-8:  Death rates from cardiovascular disease in selected countries in Africa and the Middle 
East. Adapted from Almahmeed et al., 2012. 
When looking at a figure of the proportion of years of life lost (YLL)1 due to IHD (Figure 2-9) one can 
see that it was one of the leading causes of premature deaths in North Africa and the Middle East (Roth 
et al., 2015). Popkin, Adair and Ng (2012) attribute these high figures to a change in dietary habits (from 
a traditional diet to one of more processed foods which are higher in calories) that leads to an increase 
in obesity. Another reason for this might be that the prevalence of smoking is widespread in the general 
population of the Middle East as well as North Africa, as found by Alzaabi et al. (2017), even though 
their study was not conducted to evaluate the incidence or risks for CAD. 
1 Years of life lost (YLL) is a measure of premature mortality calculated across countries. using a normative goal for survival 
computed from the lowest observed death rate 
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In Figure 2-9, Roth et al. (2015) also demonstrate that the proportion of years of life lost in Sub-Saharan 
Africa due to IHD is relatively low compared to North Africa and the Middle East. This is supported by 
Forouzanfar et al. (2012) who also reported that IHD in the southern regions of Africa is quite rare. The 
difference between the figures in the northern regions of Africa and the southern regions might be 
because people who live in northern parts of Africa are wealthier and have a higher life-expectancy than 
those living in other regions of Africa (The World Bank, 2018). Another reason may be that it is not so 
much IHD that drives cardiovascular disease mortality in sub-Saharan Africa, but rather hypertension 
that leads to hypertensive heart disease (Fuster & Kelly, 2010). In 2001, Sub-Saharan Africa was one of 
only two world regions where IHD was not the leading cause of death (Finegold et al., 2013). 
There is, however, a significant problem when comparing IHD figures between North – and Southern 
Africa: Epidemiological data in the southern regions of Africa, is scanty and aged, and the majority of 
this regions’ estimates comes from SA alone (Moran et al., 2012). 
Another plausible explanation for the lower IHD figures in Sub-Saharan Africa is that people in this 
region tend to have a shorter life expectancy and are therefore not at risk for CAD (Steyn et al., 2005). 
In spite of this, data suggests that the incidence of heart diseases normally thought of as “Western 
diseases”, such as CAD, is on the rise throughout Africa (World Health Organization African Regional 
Office, 2006). This was seen in Accra, the capital of Ghana, where cardiovascular diseases (including 
CAD) rose to being the leading cause of death in 1991 and 2001 after being in seventh place in 1953 and 
tenth place in 1966 (Agyei-Mensah & De-Graft Aikins, 2010). The incidence of CAD is still low in 
Nigeria, but also on the rise (Essien et al., 2014). CAD incidence will continue to rise with the age-
standardised mortality rates2 increasing with 74% in African men and 70% in African women by the 
year 2030 (Onen, 2013). In fact, CAD is predicted to be one of the leading causes of morbidity and 
mortality by 2020 for most developing nations (Celermajer et al., 2012), which includes those on the 
African continent.  
2 The age-standardized mortality rate is a weighted average of the age-specific mortality rates per 100,000 persons, where the 
weights are the proportions of persons in the corresponding age groups of the WHO standard population. 
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Figure 2-9:  Proportion of years of life lost (YLL) due to cardiovascular disease in 2013, stratified by global region. Adapted from Roth et al., 2015. 
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2.7. Lack of epidemiological data from Southern Africa 
Geographically speaking, the Southern region of Africa can be divided into two large countries 
(Botswana and Namibia), both with small populations, and the two small kingdoms of Swaziland and 
Lesotho. These are surrounded by SA which is the wealthiest country with the highest population in 
the entire region (Keates et al., 2017). Since the end of Apartheid in 1994, SA has undergone a 
relatively peaceful transition to a constitutional democracy (Mayosi & Benatar, 2014). However, social 
disparity still exists, as many households do not yet have access to basic services such as healthcare 
and clean water (Kahn et al., 2012; Padayachee & Desai, n.d.). 
SA has also seen a very interesting fluctuation in life expectancy3over the past six decades. In 1960 
the average life expectancy was 52 years of age. This figure increased steadily, to 62 years of age in 
1990. Thereafter it plummeted back to 52 years of age in 2005, from where it has climbed steeply back 
to 62 years of age in 2015, as depicted in Figure 2-10 (The World Bank, 2018). The reason for this 
sudden drop in life expectancy may be that in 2007, an estimated 5.7 million adults and children in SA 
were living with Human Immunodeficiency Virus (HIV) (The Joint United Nations Programme on 
HIV/AIDS & World Health Organization, 2008). The subsequent rise in life expectancy since that 
time is largely due to the increased availability of antiretroviral medication to HIV positive individuals, 
according to Statistics SA’s statistician general, Pali Lehohla (British Broadcasting Corporation (BBC) 
News, 2014). 
 
3 Life expectancy at birth indicates the number of years a new-born infant would live if prevailing patterns of mortality at 
the time of its birth were to stay the same throughout its life. 
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Figure 2-10:  Life expectancy trend in South Africa. Adapted from:  
https://data.worldbank.org/indicator/SP.DYN.LE00.IN?end=2015&locations=ZA&start=1960&view
=chart 
Even though accessibility to anti-retroviral treatment has improved tremendously, SA is overburdened 
with infectious diseases, while at the same time seeing a rise in non-communicable diseases which are 
mainly due to an aging population and the increased prevalence of hypertension (Bradshaw et al., 
2003; Mayosi et al., 2009). 
Ntsekhe and Mayosi (2009) concluded that CAD is not a significant problem for individuals who live 
with HIV, in Sub-Saharan Africa. The major problem with this is that the weight loss and early 
mortality associated with HIV (Almahmeed et al., 2012) can ultimately mask the risk factors4 for CAD 
(Houle et al., 2014); as a result a chronic disease like this will not be given a very high priority or 
adequate resources in the healthcare sector (World Health Organization African Regional Office, 
2006), making CAD seem like an unimportant problem. 
The sad fact is that because atherosclerosis takes a long time to develop and does so silently (Sayols-
Baixeras et al., 2014), and because anti-retroviral treatment campaigns are affective in further reducing 
4 See 2.3. Risk factors associated with CAD. 
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HIV mortality rates, SA’s non-communicable disease burden will continue to rise (Mayosi & Benatar, 
2014) and Mayosi et al. (2012) reports that SA’s exposure to modifiable risk factors for cardiovascular 
disease is indeed rising. It is also clear that the healthcare sector are aware of this health transition that 
is taking place, but not much is known regarding the consequences thereof (Gómez-Olivé et al., 2018). 
For this reason empirical research is of vital importance, especially at local, national and regional 
levels (Houle et al., 2014). 
2.7.1. Lack of epidemiological data from central South Africa 
Though most of the estimates for IHD in Sub-Saharan Africa come from SA alone (Moran et al., 
2012)5, while reviewing the literature it was found that there is significant lack of data from SA, and 
especially from central SA. This is evident in the fact that the last data, regarding SA’s IHD mortality 
figures, was submitted to the WHO in 2009! That is ten years ago, and the reason for this is not known 
(Nowbar et al., 2014). Mayosi et al. (2009) also found that data needed to track the prevalence of 
different risk factors for non-communicable diseases in SA, such as IHD, is scant indeed. 
When searching for publications regarding central SA’s IHD situation, the results are disappointing 
and unsatisfactory. For the last three decades only a limited number of journals have published studies 
related to the risk factors for IHD in SA could be identified, and three of these were published before 
1994, as shown in Table 2-26. One recent study that could be found showed that in Durban, from 2008 
to 2012, a staggering 83% of acute myocardial infarctions among black African patients were caused 
by STEMI and only 17% by NSTEMI (Masina et al., 2016). Another recent study showed risk factor 
increases of epidemic proportions in the Indian population of Durban, with high prevalence of 
hypertension (47.5%), diabetes mellitus (20.1 %) and total body obesity (raised body mass index) 
(32.4%) (Prakaschandra et al., 2016). This emphasises the need for research into similar trends in 
central SA. 
Sliwa et al. (2008) attributes the rise in non-communicable diseases, or epidemiological transitioning, 
to SA’s extreme population diversity that ranges from industrialized cities, where people follow an 
urban lifestyle, to rural regions where people lead more traditional lives. Persons living in rural areas 
5 See 2.6. African figures of CAD 
6 Only publications that came out of SA itself were included. Publications before 1990 were not included. 
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tend to be more physically active as a part of their daily living (farming, performing their own 
housework, walking longer distances between destinations etc.) and they tend to eat healthier food 
(less processed food that does not contain artificial preservative substances, or food that is often grown 
by the consumers themselves). Those who become urbanised, however, often replace these salutary 
habits with a diet of sugary, salty and fatty foods, and tend to settle into sedentary jobs (World Health 
Organization African Regional Office, 2006). 
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Table 2-2: Summary of publications from South Africa related to this study. 
Reference Publication name Year Main finding/s pertaining to this study Comments 
Seedat et al., 
1990 
Risk factors for coronary 
heart disease in the Indians of 
Durban 
1990 In a study of 778 subjects aged 15 - 69 years (408 men), 15,3% (sex and age 
adjusted 13,4%) had a history of CHD. The important risk factors in men were 
hypercholesterolaemia, hypertriglyceridemia, diabetes, and smoking, and in 
women diabetes, hypercholesterolaemia, and hypertriglyceridemia. This study 
showed that the risk factors leading to coronary heart disease in Indians were 
similar to the Afrikaans-speaking whites, except that diabetes was common in the 
Indian population. 
A positive history of CHD was obtained from 12% of the men and 18,9% of 
the women, i.e. 15,3% of respondents in the total sample. 
Venter et al., 
2015 
Autopsies performed at 
Universitas Academic 
Hospital, South Africa, 
1990–2010, and perceptions 
and opinions of health 
professionals on the 





The percentage of deaths caused by the cardiovascular system decreased from 12% 
in 1990 to 3% in 2010. 
Prevalence of CAD not addressed in this study. 
The nature of the 
cardiovascular disease is not 
reported 
Steyn et al., 
1991 
Risk factors for coronary 
heart disease in the black 
population of the Cape 
Peninsula. The BRISK study. 
1991 Percentages of deaths from IHD in the Cape Peninsula (15 - 64 years) were as 
follows:  22,5% for males and 13,3% for females. Among males the bulk of the risk 
was due to the smoking of cigarettes, while among females the biggest contribution 
to the risk profile was made by hypertension. 
IHD accounted for 22,5% of deaths in males and 13,3% of deaths in females. 
Absolute rates could not be 
calculated because of 
considerable uncertainties 
about the true size of the 
black population. 
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Reference Publication name Year Main finding/s pertaining to this study Comments 
Steyn et al., 
1992 
The impact of chronic 
diseases of lifestyle and their 
major risk factors on 
mortality in South Africa 
1992 IHD caused 8.7% of all deaths and 9.6% of deaths in individuals between the 
ages of 35 and 64. 
Out of the total of 4.88 million smokers throughout SA, the largest group of was 
black males (2.6 million). For hypertension, 5.5 million South Africans had blood 
pressures above 140/90 mmHg and again the largest group was black people (3.0 
million). 4.8 Million South Africans had hypercholesterolemia and 3.1 million 
South Africans had raised LDL cholesterol levels, with black individuals having 
the lowest levels. 
The results were based on the 
size of the SA population 




Coronary heart disease risk 
factors in a rural and urban 
Orange Free State black 
population 
1995 The age- and sex-adjusted prevalence of hypertension were 29% in QwaQwa and 
30,3% in Mangaung. Diabetes was present in 4,8% of the QwaQwa sample and 6% 
of the Mangaung sample. The prevalence of heavy smoking in the Mangaung 
sample was almost double that of the QwaQwa sample and mostly confined to men. 
The incidence of CAD was not assessed, only the risk factors for CAD, but 
according to Walker and Walker (1985) incidence of CAD was estimated at 10 
per 100 000 for the population of Soweto. 
Risk factors were only 
evaluated in individuals of 25 
years and older 
Ubbink et al., 
1995 
Effective homocysteine 
metabolism may protect 
South African blacks against 
coronary heart disease 
1995 Blacks metabolized homocysteine more effectively than did whites, which may 
partly explain their relative resistance against coronary heart disease despite a high 
prevalence of obesity, hypertension, and smoking. 
The prevalence of CHD was not assessed, but this study was done on the 
assumption that CHD in the SA black population is rare, despite widespread 
westernization. 
The study samples were very 
small in whites (n = 18) as 
well as blacks (n = 12). 
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Reference Publication name Year Main finding/s pertaining to this study Comments 
Metcalf et al., 
1996 
Design and baseline 
characteristics of a 
hypertension intervention 
program in a South African 
village 
1996 The age-adjusted prevalence of hypertension in people aged 15 years or more was 
13.9% in men and 16.3% in women. 
The prevalence of CAD was not assessed in this study. 
This survey only assessed a 
rural community of Mamre, 
located in the Western Cape. 
Steyn et al., 
1996 
Estimation of the prevalence 
of familial 
hypercholesterolaemia in a 
rural Afrikaner community 
by direct screening for three 
Afrikaner founder low 
density lipoprotein receptor 
gene mutations 
1996 There are about 112 000 familial hypercholesterolemia patients in the country who 
are underdiagnosed as a group and therefore not receiving the care that would help 
to reduce the burden of familial hypercholesterolemia-associated IHD in SA. 
This study did not assess the prevalence of CAD. 
This study only assessed 




Coronary heart disease:  
Outlook for Africa 
1997 In the urban African population CHD is rare (±0.2%of the roughly 20000 
deaths occurring annually in Soweto). However, there is a rising prevalence of 
virtually all risk factors for the disease. 
Sitas et al., 
2004 
Tobacco attributable deaths 
in South Africa 
1998 In 1998, about 8% of all adult deaths in SA (more than 20 000 deaths a year) were 
caused by smoking. About 8% of adult deaths (21 500 deaths per year) in SA could 
be attributed to smoking. 





A Comparative Risk 
Assessment for South Africa 
in 2000: Towards Promoting 
Health and Preventing 
Disease 
2000 IHD (as a condition) was the cause of 6.6% of all deaths in 2000. 
Deaths attributable to risk factors were as follows: Hypertension 9%, Smoking 
8.5%, Excess body weight 7.0%, High cholesterol 4.6%, Diabetes 4.3%. 
Data reported for the whole 
of SA, although there might 
be differences in risk profiles 
for different sub-populations. 
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Reference Publication name Year Main finding/s pertaining to this study Comments 
Bradshaw et 
al., 2007 
Estimating the burden of 
disease attributable to 
diabetes in South Africa in 
2000 
2000 Of South Africans aged >30 years, 5.5% had diabetes which increased with age. 
Overall, about 14% of IHD, 10% of stroke, 12% of hypertensive disease and 12% 
of renal disease burden in adult males and females (30+ years) were attributable to 
diabetes. 
This study focused on diabetes and did not assess the prevalence of IHD itself, 
but found that 14% of IHD was caused by diabetes. 
Study only evaluated persons 
of 30 years and older. 
Norman et al., 
2007 
Estimating the burden of 
disease attributable to high 
blood pressure in South 
Africa in 2000 
2000 42% of IHD in males and females older than 30 years were attributable to high 
blood pressure (systolic BP >115mmHg). 
This study focused on hypertension and did not assess the prevalence of IHD 
itself, but found that almost half of IHD was caused by high blood pressure. 
Norman, 
Bradshaw, 
Steyn, et al., 
2007 
Estimating the burden of 
disease attributable to high 
cholesterol in South Africa in 
2000 
2000 Overall; about 59% of IHD and 29% of ischemic stroke burden in adult males and 
females (30+ years) were attributable to high cholesterol (>3.8 mmol/L) with 
marked variation by population group. 
This study focused on high cholesterol and did not assess the prevalence of 
IHD itself, but found that high cholesterol contributed significantly to the IHD 
burden. 
Joubert et al., 
2007 
Estimating the burden of 
disease attributable to 
physical inactivity in South 
Africa in 2000 
2000 Overall, in adults > 15 years in 2000, 30% of IHD were attributable to physical 
inactivity. Compared to the global average, SA adults had a particularly high 
prevalence of physical inactivity. 
This study focused on physical inactivity and did not assess the total 
prevalence of IHD itself, but found that physical inactivity caused one third of 
the IHD burden. 
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Reference Publication name Year Main finding/s pertaining to this study Comments 
Joubert et al., 
2000 
Ischaemic Heart Disease in 
Black South African Stroke 
Patients 
2000 Coronary vessel stenosis of >50% was observed in >1 of the coronary arteries in 
over half of all necropsy patients examined, and 17.4% had histological evidence 
of previous myocardial infarction. 
The prevalence of CAD in black African stroke patients was significantly 
higher than has been documented in the general non-stroke black population 
as well as in stroke patients. Black stroke patients may have a risk for CAD similar 
to that of their white counterparts. 
This study only examined 
CAD in stroke patients. 
Bourne et al., 
2002 
Where does the black 
population of South Africa 
stand on the nutrition 
transition? 
2002 31.8% of African women were obese (body mass index (BMI) ≥ 30 kg/m²) and a 
further 26.7% were overweight (BMI ≥ 25 to ,30 kg/m²). The obesity prevalence 
among men was 6.0%, with 19.4% being overweight. The national prevalence of 
hypertension in blacks was 24.4%, using the cut-off point of 140/90mmHg. 
This study did not focus on the prevalence of IHD, but rather on selected risk 
factors related to the emergence of non- communicable diseases in the black 
population of SA 
Only black adults over the 
age of 15 years were 
examined 
Department of 
Health et al., 
2007 
South Africa Demographic 
and Health Survey 2003 
2003 12.5% of men and 17.9% of women were hypertensive and more than 70% of 
hypertensive patients in SA has uncontrolled hypertension. 35%of men and 10% of 
women smoke cigarettes either daily or occasionally. 
IHD self-reported prevalence in men was 6% while the self-reported 
prevalence among women was 8% (Because the prevalence of IHD is usually 
higher in men than in woman, this may be indicative of the inaccuracy of self-
reported IHD. It is also possible that IHD is interpreted more so by female 
than male older respondents to mean ‘all heart disease’.). 
A family history of IHD was reported by 11 percent of men and 14 percent of 
women, a slight decrease from the 1998 figures of 13 and 16 percent 
respectively. 
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Reference Publication name Year Main finding/s pertaining to this study Comments 
Alberts et al., 
2005 
Prevalence of cardiovascular 
diseases and associated risk 
factors in a rural black 
population of South Africa 
2005 A sample of 1608 women and 498 men aged 30 years and above participated in the 
study. There was a high prevalence of tobacco use for men (57%) and women 
(35.4%). 51.7% of women were either overweight or obese. Diabetes was 
diagnosed in 8.8 and 8.5% of women and men, respectively. Hypertension (blood 
pressure >140/90mmHg) was found in 25.5% of women and 21.6% of men. 
The data presented in this study did not focus on the prevalence of IHD, but 
have highlighted the finding that even rural black people in SA have a 
cardiovascular disease risk profile that predisposes them to the emergence of 
atherosclerosis and related chronic diseases. 
Study done in a rural adult 
black population from 
Limpopo Province. 
This study did not include a 
dietary survey to determine 
whether the results were due 
to eating habits. 
Rosana 
Norman et al., 
2007 
Estimating the burden of 
disease attributable to high 
blood pressure in South 
Africa in 2000 
2007 50% of stroke, 42% of IHD, 72% of hypertensive heart disease and 22% of other 
cardiovascular diseases in males and females >30 years of age were caused by 
systolic blood pressure ≥115mmHg. 
Although this study did not focus on the prevalence of IHD, it did find that 
42% of IHD was caused by a systolic blood pressure of >115mmHg in adults 
older than 30 years. 
Only adults ≥30 years of age 
were studied 
Prakaschandra 
et al., 2016 
High prevalence of 
cardiovascular risk factors in 
Durban South African 





There was high prevalence of hypertension (47.5%), diabetes mellitus (20.1%) and 
total body obesity (raised body mass index) (32.4%), as well as increased waist 
circumference (73.1%). Over half of the males and 14.6% of females were current 
smokers. 
This study did not focus on the prevalence of IHD. 
There were low response 
rates of male participants. 
Bärnighausen 
et al., 2008 
Hiding in the shadows of the 
HIV epidemic: Obesity and 
hypertension in a rural 
population with very high 
HIV prevalence in South 
Africa 
2008 From 2003 to 2004, in rural uMkhanyakude, KwaZulu-Natal, the crude prevalence 
of obesity and hypertension was 32% and 33% respectively, despite a very high 
HIV prevalence. The percentage of overweight people was 58%. 
This study did not focus on the prevalence of IHD. 
This study was conducted at a 
time when antiretroviral 
treatment was not yet widely 
available in SA, except to the 
few people able to afford 
private care. 
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Reference Publication name Year Main finding/s pertaining to this study Comments 
Sliwa et al., 
2008 
Spectrum of heart disease 
and risk factors in a black 
urban population in South 
Africa (the Heart of Soweto 
Study): a cohort study. 
2008 Prevalence of cardiovascular risk factors was very high, with 56% of patients 
diagnosed with hypertension (44% of whom were also obese). Only 13% of patients 
had no identifiable risk factors, whereas 59% had several risk factors. 
Out of the total 1593 new cases of cardiovascular disease, 165 patients had 
CAD (10%) and 28 had CAD without risk factors (17%). Black Africans were 
far less likely to be diagnosed with CAD than were all other racial groups (77 
[6%] vs 88 [38%]). Proportionately fewer women than men were diagnosed 
CAD (68 [7%] vs 97 [15%]). 
Since not all patients being 
managed by the cardiology 
unit were captured by the 
registry, selection bias might 
exist 
Erasmus et al., 
2012 
High prevalence of diabetes 
mellitus and metabolic 
syndrome in a South African 
coloured population: 
Baseline data of a study in 




This study showed a crude prevalence of 28.2% of type 2 diabetes in an urban 
community of Bellville South, Cape Town. 
This study did not focus on the prevalence of CAD. 
The nature of this study is 
cross-sectional, with high 
female-to-male participation, 
which is a common trend in 
SA population studies. 
Masina et al., 
2016 
Risk factor assessment in 
South African Black patients 
presenting with acute 
myocardial infarction at R.K. 




The majority presented with ST-elevation myocardial infarction (STEMI) (83%) 
whilst 17% had Non-ST-Elevation Myocardial Infarction (NSTEMI). Smoking 
(48%) and hypertension (46%) were the most commonly observed risk factors. 
Only patients with acute 
myocardial infarction who 
were of Black SA origin 
(n=94) were analysed. 
Mayosi et al., 
2009 
The burden of non-
communicable diseases in 
South Africa 
2009 Non-communicable diseases are emerging in both rural and urban areas, most 
prominently in poor people living in urban settings, and are resulting in increasing 
pressure on acute and chronic health-care services. 
IHD accounts for only 10% of patients presenting to hospital with heart 
disease, in the black population. The favourable total cholesterol profile in 
association with very high levels of the protective HDL cholesterol in more 
than 80% of black South Africans is thought to be the reason for the fairly low 
prevalence of IHD in this population. 
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Reference Publication name Year Main finding/s pertaining to this study Comments 
Brand et al., 
2013 
Chronic diseases are not 
being managed effectively in 
either high-risk or low-risk 
populations in South Africa 
2013 In a group of randomly selected families of black African descent (Nguni and Sotho 
chiefdoms) from Johannesburg’s South Western Townships (Soweto): 
39% were obese, 42% were hypertensive, 40% were current/previous smokers, and 
8% had Diabetes Mellitus. 
This study did not focus on the prevalence of IHD. 
Cardiovascular risk-factor 
management was studied with 
the focus on critical limb 
ischemia 
Roos et al., 
2013 
Physical Activity Levels and 
Activity Preferences of a 
Cohort of South African 
Individuals Living With HIV 
2013 Physical inactivity was present in the majority of study participants (n=195) as they 
took less than the recommended 10000 steps per day. Intervention programmes 
addressing this risk factor for IHD at a primary care level could potentially lessen 
the future burden of disease related to inactivity. 
Although this study did not focus on the prevalence of IHD, they did note that 
30% of IHD cases in SA are attributed to physical inactivity. 
This study only evaluated the 
physical activity levels of 
individuals living with HIV. 
Mayosi & 
Benatar, 2014 
Health and Health Care in 
South Africa — 20 Years 
after Mandela 
2014 When looking at years of life lost, IHD was ranked 7th (3.2% of total) among 
the causes of premature death in 1990 and decreased to the 10th rank (1.6% of 
total) in 2010. 
The highest proportion of disability-adjusted life-years lost is attributable to alcohol 
use, a high body-mass index, and high blood pressure. 
Houle et al., 
2014 
The unfolding counter-
transition in rural South 
Africa: Mortality and cause 
of death, 1994-2009 
2014 Non-communicable diseases have increased steadily over time. For non-
communicable diseases the probability of dying for both females and males has 
slowly increased over time periods relative to 1994– 1997, particularly since 2002. 
The probability of dying from non-communicable diseases was higher among 
males than females. 
This study did not focus on the prevalence of IHD itself, but rather non-
communicable diseases as a group. 
This data is from a defined 
geographic region within SA: 
the Agincourt sub-district of 
Bushbuckridge, Mpumalanga 
Province. 
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Reference Publication name Year Main finding/s pertaining to this study Comments 
Gaziano et al., 
2017 
Cardiometabolic risk in a 
population of older adults 
with multiple co-morbidities 
in rural South Africa: the 
HAALSI (Health and Aging 
in Africa: longitudinal studies 
of INDEPTH communities) 
study 
2017 70% of women and 44% of men were overweight or obese. Blood pressure was 
similar for men and women with a combined hypertension prevalence of 58.4% 
and statistically significant increases were observed with increasing age. High total 
cholesterol prevalence in women was twice that observed for men (8.5 vs. 4.1%). 
The self-reported prevalence of “heart attacks” (therefore CAD) were 0.5% in 
males and 0.4% in females. Total study cohort consisted of 5059 patients who 
were interviewed. 
This data has limitations 
associated with all cross-
sectional assessments, 
limiting the extent to which 
causal inferences can be 
made. 
Gómez-Olivé 
et al., 2018 
Cohort Profile: Health and 
Ageing in Africa: a 
Longitudinal Study of an 
INDEPTH Community in 
South Africa (HAALSI) 
2018 More than 50% of male and more than 60% of female participants had 
hypertension. 44% of male and 69.6% of female participants were overweight or 
obese. 4.2% of male and 8.5% of female participants had high cholesterol. 19.2% 
of male and 0.4% of female participants use tobacco. 
The self-reported prevalence of myocardial infarction (therefore CAD was 
0.4% in both males and females. See previous study. 
This was not a nationally 
representative sample, but 
HAALSI findings are likely 
to be mirrored in similar rural 
communities. 
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Published information on the demographics and epidemiology of patients with CAD in central SA could not 
be found, and there is a critical scarcity of publications from this region. By not researching the factors that 
contribute to CAD, especially the demographics, healthcare disparities might exist in the treatment strategies 
of a disease such as this (Taylor et al., 2005). 
In order to effectively allocate public health resources, governments are in need of accurate statistics on 
diseases (Moran et al., 2012). Currently a large portion of the SA population receives subsidized healthcare 
from the government, making the treatment of cardiovascular disease a costly affair (Watkins et al., 2016). 
The programmers and policymakers of the public healthcare sector also have to work whilst trying to 
overcome the critical barrier of a lack of data with which to determine the effects of a health transition, 
especially with regards to cardio-metabolic disease (Gaziano et al., 2017). 
The first step that those responsible for the implementation of government programmes need to take in order 
to address this problem is to determine the nature and extent of the risk factors for CAD (Fuster & Kelly, 
2010). This can be done by supporting research (such as this study) that seeks to quantify disease burdens in 
a particular area so that trends may be determined and effective (and potentially cost-saving) intervention 
plans implemented (Houle et al., 2014). 
2.8. Universitas Academic Hospital (UAH) 
UAH is a part of the Bloemfontein Academic Hospital Complex, and is associated with the University of the 
Free State. This is a tertiary hospital that acts as a referral hospital for smaller hospitals and clinics in the 
central SA region. UAH is the only tertiary referral facility for the public sector in the central SA region and 
mainly serves patients from the Free State, Northern Cape and Lesotho. It is also the sole tertiary care 
referring public institution for this region. This region consists of roughly 6,23 million people (Free State, 
Northern Cape and Lesotho) (Stats SA, 2019; World Population Review, 2019). 
To date only one study related to cardiovascular disease, which was conducted at UAH, could be found. This 
study was undertaken in order to assess a perceived decrease in the number of autopsies requested at the 
UAH in Bloemfontein. Unfortunately the nature of the cardiovascular disease that was discussed in this study 
was not reported, as outlined in Table 2-2 (Venter et al., 2015). 
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The CAD profile of patients presenting for coronary angiography at UAH have not been documented in the 
past. There is a critical scarcity of publications on this subject in central SA, especially the Free State, as seen 
in Table 2-2. This means that trends of non-modifiable CAD risk factors over the past two decades have not 
yet been identified. 
2.9. Significance of this study 
From Table 2-2 (page 28) one can see that there exists the definite presence of risk factors for CAD in the 
rest of SA. Coronary angiography was performed on 640 patients during 1994 compared to 631 in 2014. If 
the profile of these patients can be identified then more focused research can be undertaken in fields such as 
prevention, diagnosis, treatment and health resource planning; this will in turn lead to improved patient 
outcome and the reduced cost of healthcare for the public sector. In his maiden State of the Nation Address, 
even newly-elected President Cyril Ramaphosa stressed the need for confronting lifestyle diseases such as 
cardiovascular disorders, hypertension and diabetes (Ramaphosa, 2018). This can be achieved by the study 
of population differences and by subsequently conducting focused studies, which will then lead to enhanced 
treatment strategies among different population groups (Taylor et al., 2005). 
In order to implement effective action against CAD, research is needed into the extent of CAD, as well as its 
risk factors (Mayosi et al., 2012). This study was undertaken because almost no published information is 
available on the profile and risk factors of CAD in patients of central SA, specifically those presenting at 
UAH. To my knowledge this was the first population-based study on this subject in this region. With this 
Master’s degree a contribution can be made to the improvement of CAD prevention planning. This study, 
which included only public sector patients, was the first step in generating possible hypotheses for more 
individual-level research, which is important for policy makers at a population level (Forouzanfar et al., 
2012).  
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Abstract 
Studies report that coronary artery disease (CAD) in Sub-Saharan Africa is rare but epidemiological data of this region 
is scanty. No CAD data exists for central South Africa (SA). 
Aim 
To document the profile of CAD in public sector patients in central SA and determine if there was a change over twenty 
years. 
Methods 
Retrospective observational study comparing patients with confirmed CAD, on coronary angiography, of 2014 to 1994 
in central SA. 
Results 
Acute coronary syndrome (ACS) increased significantly (p<0,0001). There was a notable increase in Non-ST-
Elevation Myocardial Infarction (NSTEMI) (p<0,0001) and ST-Elevation Myocardial Infarction (STEMI) (p<0,0001). 
African patients with STEMI increased significantly [1994: n=8 (8,5%); 2014: n=45 (29,4%); (p<0,0001)]. Caucasian 
patients with ACS decreased [1994: n=240 (92%); 2014: n=192 (56,8%); (p=0,0015)], but NSTEMI in this group 
increased significantly [1994: n=12 (75%); 2014: n=75 (65,8%); (p<0,0001)]. 
Conclusions 
ACS rose significantly over time and STEMI is the most important presenting condition in African patients. Chest pain 
in African patients should not be ignored by clinicians. 
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Coronary artery disease (CAD) is the leading non-communicable cause of death in developed countries and 
is responsible for about one third of all deaths in adults (Sanchis-Gomar et al., 2016). Worldwide it is 
estimated that approximately 153.5 million people are affected, with higher prevalence in males than females 
(Benjamin et al., 2019). Annually about 3.8 million men and 3.4 million women die due to CAD worldwide 
(Clarify Registry Investigators, 2018). 
In developing countries such as India, Egypt and Pakistan, CAD is reported to be on the rise (Sriharibabu, 
2016; Prabhakaran et al., 2018). This trend can be seen in most developing countries. Between 1984 and 
1999 Beijing’s coronary heart disease mortality rates increased by 27% in women and a staggering 50% in 
men (1608 more deaths than expected from baseline mortality rates in 1984 among patients aged 35 to 74 
years) (Critchley et al., 2004). In North Africa, Tunisia experienced increased CAD mortality rates of 11,8% 
in men (from 70 to 87 deaths per 100,000) and 23,8% in women (from 28 to 41 deaths per 100,000) from 
1997 to 2009 (Saidi et al., 2013). 
CAD in the southern regions of Africa is perceived to be rare (Forouzanfar et al., 2012). Reports from the 
World Health Organization (WHO) African region suggests that non-communicable diseases in Sub-Saharan 
Africa, as well as the costs related to their treatment, are on the rise (World Health Organization African 
Regional Office, 2018). Epidemiological data of the southern regions of Africa is scanty and aged; most of 
this regions’ estimates comes from South Africa (SA) alone (Moran et al., 2012). Cardiovascular diseases 
(including CAD) rose to being the leading cause of death in Ghana’s capital, Accra, in 1991 and 2001 after 
being in seventh place in 1953 and tenth place in 1966 (Agyei-Mensah & De-Graft Aikins, 2010). The 
incidence of CAD is still low in Nigeria, but is also on the rise (Essien et al., 2014). CAD is predicted to be 
one of the leading causes of morbidity and mortality by 2020 for most developing nations (Celermajer et al., 
2012). The rise in CAD in African populations is generally ascribed to the increase in modifiable risk factors 
for CAD, which include hypertension, diabetes mellitus, hypercholesterolemia, smoking and obesity (Yusuf 
et al., 2001a; Gersh et al., 2010; Nowbar et al., 2019; Benjamin et al., 2019). 
In SA ischaemic heart disease is the ninth leading cause of death (Statistics South Africa, 2016). However, 
limited data about this topic is available. The only major studies available for SA are the Heart of Soweto 
study and the work of Prof. Bongani M Mayosi. These studies report that the prevalence of modifiable risk 
factors for CAD is high and rising, especially in the black African population (Sliwa et al., 2008; Tibazarwa 
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et al., 2009; Mayosi et al., 2009; Stewart et al., 2011; Mayosi et al., 2012; Mayosi & Benatar, 2014; Masina 
et al., 2016). Therefore, emphasizing the need for epidemiological studies into this phenomenon (Stewart et 
al., 2006; Sliwa & Mocumbi, 2010; Senkubuge & Mayosi, 2013; Masina et al., 2016; Prakaschandra et al., 
2016). 
No CAD epidemiological data exists for central SA. The primary aim of this study was to document the 
profile of patients who had confirmed CAD, on coronary angiography, in the public sector of central SA. 
Since this was a pilot study the main objective was to determine whether there was a change in non-
modifiable risk factors over a twenty-year period. 
Methods 
Study design and location 
A retrospective single-centre observational cohort comparing two time periods, twenty years apart, was 
conducted at Universitas Academic Hospital (UAH), Bloemfontein. UAH is the only tertiary referral facility 
for the central SA region and mainly serves patients from the Free State, Northern Cape and Lesotho. It is 
also the sole tertiary care referring public institution for this region. This region consists of roughly 6,23 
million people (Free State, Northern Cape and Lesotho) (Stats SA, 2019; World Population Review, 2019). 
Study population and data collection 
The main inclusion criterion was confirmed atherosclerotic CAD as reported on coronary angiography. 
Medical records/data of all public sector patients who underwent coronary angiography during 1994 and 
2014 were evaluated. Information was collected using physical catheterization laboratory and cardiothoracic 
theatre registries, clinical patient files as well as a computerized surgical database (cardiothoracic surgical 
patients only). Patients who had previous Coronary Artery Bypass Graft (CABG) surgery and previous 
Percutaneous Coronary Intervention (PCI) were included among the patients with confirmed atherosclerotic 
CAD. 
Data was captured using Excel spreadsheets. Demographic data, which forms part of the non-modifiable risk 
factors for CAD, and other relevant clinical information was recorded. This included age, gender, ethnicity, 
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region of origin, family history of heart disease, clinical diagnosis (indication for coronary angiography), 
final angiographic diagnosis (vessels affected) and treatment. 
Definitions 
CAD was defined as atherosclerotic build-up on the inner lumen of coronary arteries as recorded in clinical 
records by a cardiologist (Mendis et al., 2011). 
The following definitions were used because of the historical nature of 1994 data: non-Q wave infarction 
(also labelled as “subendocardial infarction” or “limited infarction”) was considered similar to Non-ST-
Elevation Myocardial Infarction (NSTEMI) and transmural infarctions were defined as modern day ST-
Elevation Myocardial Infarction (STEMI) (Gorlin et al., 1986; Montague et al., 1988; Saleh & Ambrose, 
2018). 
In 2014 the terms STEMI and NSTEMI were used based on changes seen on the ECG and the presence of 
cardiac biomarkers according to modern day guidelines (Thygesen et al., 2007; Mendis et al., 2011; Thygesen 
et al., 2012; Saleh & Ambrose, 2018). 
Unstable angina included crescendo angina which was defined as “ the sudden acceleration and 
intensification of existing angina” (Braunwald, 2012) and Prinzmetal angina (a variant form of angina 
associated with cyclical rest pain of long duration and transient ST-segment elevation) (Prinzmetal et al., 
1959; Allaire & Schroeder, 1975; Huckell et al., 1981). Angina was classified as unspecified when clinical 
records did not state whether it was stable, unstable, Prinzmetal or crescendo angina. To ensure the accuracy 
of data, unspecified angina was not included in the ACS group. 
“Other” clinical indications included: Heart muscle disease (Dilated/Hypertrophic/Restrictive 
Cardiomyopathy), valvular and congenital heart disease, heart rhythm abnormalities, tumours and masses, 
syncope, peripheral vascular disease, pulmonary hypertension/oedema and aortic aneurysms/dissections. 
Ethics 
This study was approved by the Health Sciences Research Ethics Committee (HSREC) of the University of 
the Free State (UFS-HSD2019/0053/2304) as well as the Free State Department of Health (DOH) and was 
conducted according to the principles of the Declaration of Helsinki (World Medical Association, 2013). 
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Statistical analysis was done in collaboration with a biostatistician affiliated with the Robert Frater 
Cardiovascular Research Centre. A t-test was used to compare normally distributed data. Comparisons were 
carried out using a Chi square test or Fisher’s exact test. Analysis was done using R-software (R Core Team, 
2019). A p-value of <0,05 was considered significant. Subgroup analysis was performed with unpaired t-
tests and 95% confidence interval based on ethnicity, gender and age. 
Results 
Coronary angiography was performed on 640 patients during 1994 and 631 in 2014. Healthy coronary 
arteries (no atherosclerosis) was observed in 165 (25,8%) of the 1994 cohort and 171 (27,1%) of the 2014 
cohort; in 15 (2,3%) of the 1994 cohort angiographic diagnosis was undocumented. Interestingly, an identical 
number (460) of angiographically-confirmed atherosclerotic CAD was demonstrated in both cohorts [1994: 
n=460 (71,9%); 2014: n=460 (72,9%)]; this was an incidental finding and groups were not selected to be 
similar. 
Coronary artery disease (1994, n=460; 2014, n=460) 
Non-modifiable risk factors 
Demographic data of patients with confirmed CAD can be viewed in Table 3-1 and Figure 3-1. Patients of 
African ethnicity and mixed origins (both males and females) increased more than five-fold from 1994 to 
2014, whilst Caucasian patients decreased from a total of 431 in 1994 to 283 in 2014. CAD was present in 
about two-thirds of males in both cohorts [1994: n=319 (69,3%); 2014: n=308 (67,0%)]. Subgroup analysis 
(based on age, gender and ethnicity) showed that Caucasian males with CAD were slightly older in 2014 
(median age = 63 years) than in 1994 (median age = 61 years) (p=0,0073, 95% CI -4.8602; -0.7624). No 
significant differences were observed in other demographic groups. Family history of heart disease was not 
analysed since it was undocumented in a large number of patients of both cohorts [1994: n=304 (66,1%); 
2014: n=209 (45,4%)]. 
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Table 3-1: Demographic data of patients with confirmed CAD. 
 1994 (n=460) 2014 (n=460) 
 Male Female Male Female 








African ethnicity 10 51 (33-63) 5 61 (51-71) 54 56 (30-75) 27 60 
Caucasian 297 61 (29-85) 134 66 (35-84) 200 63 (26-85) 83 64 
Mixed race 7 51 (49-69) 2 60 (53-67) 40 57 (36-83) 38 61 
Indian 5 55 (44-74) 0 - 14 43 (31-62) 4 60 
 
 
Figure 3-1: Ethnicity of CAD patients. 
 
Referral patterns and clinical indications 
In both cohorts the majority of CAD patients were referred from the Free State [1994: n=352 (76,5%); 2014: 
n=300 (65,2%)]; of these, nearly half were referred from the Mangaung district (Central Free State) [1994: 
n=159 (45,2%); 2014: n=145 (48,3%)]. There was a substantial increase in the number of patients referred 
from the Northern Cape from 1994 (n=47; 10,2%) to 2014 (n=132; 28,7%). ACS was the main indication 
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for angiography in both 1994 and 2014. Clinical indications for performing coronary angiography are 
presented in Table 3-2. 






Stable angina 20 (4,3) 5 (1,1) 
Unstable angina 151 (32,8) 71 (15,4) 
NSTEMI 16 (3,5) 114 (24,8) 
STEMI 94 (20,4) 153 (33,3) 
Unspecified angina 56 (12,2) 19 (4,1) 
Atypical chest pain 1 (0,2) 3 (0,7) 
Follow-ups and positive stress testing 91 (19,8) 67 (14,6) 
Other 31 (6,7) 28 (6,1) 
 
Vessel involvement 
Bypass grafts were present in 18,5% (n=85) of the 1994 cohort and 16,5% (n=65) of the 2014 cohort. Patients 
who had patent vessels after previous PCI were slightly less in 2014 (n=5; 1,1%) than in 1994 (n=12; 2,6%). 
Of the remaining patients the majority had only one coronary artery affected by atherosclerosis in 1994, 
while more patients had three vessel disease in 2014 (Table 3-3). Subgroup analysis of vessel involvement 
(based on age, gender and ethnicity) showed no remarkable differences except that females with three vessel 
involvement presented at a younger age (median age = 64 years) in 2014 compared to 1994 (median age = 
69 years) (p=0,0294, 95% CI 0,4589; 8,4280). 
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Table 3-3: Vessel involvement of patients with confirmed CAD. 
 1994 (n=363) 2014 (n=379) 
 Male Female Male Female 
 n Age n Age n Age n Age 
One vessel         
African ethnicity 6 50 3 54 29 56 5 61 
Caucasian 77 60 49 64 38 59 17 63 
Mixed race 0 - 3 49 11 58 11 53 
Indian 1 48 0 - 4 37 1 66 
Two vessels         
African ethnicity 4 53 0 - 12 52 5 60 
Caucasian 68 62 24 70 33 59 19 63 
Mixed race 0 - 0 - 9 57 8 65 
Indian 0 - 0 - 2 40 1 57 
Three vessels         
African ethnicity 0 - 2 62 13 57 13 64 
Caucasian 82 61 35 70 78 62 28 64 
Mixed race 3 53 2 60 18 60 15 64 
Indian 0 - 4 56 7 46 2 55 
 
Treatment 
In 1994 simple PTCA was performed more frequently than in 2014 (n=65 vs. n=5); in 2014 PTCA with 
stenting tended to be more frequent (n=9 vs. n=155). CABG almost doubled over the study period (2014 
n=104 vs. 1994 n=56). It must be noted that the treatment modality of 50,7% (n=233) of patients in the 1994 
cohort and 1,1% (n=5) in the 2014 cohort could not be confirmed (files not found/incomplete clinical 
records). 
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Acute coronary syndrome (1994, n=261; 2014, n=338) 
ACS 1994 (n=261) 
The majority of ACS patients had unstable angina (n=151; 32,8%) and the minority NSTEMI (n=16; 3,5%). 
There were 94 patients (20,4%) diagnosed with STEMI. 
Non-modifiable risk factors 
Almost one third of the total 1994 ACS group was female (n=79; 30,3%). Caucasians made up 92% (n=240) 
while patients of African ethnicity were only 5% (n=13). The median age of Caucasian females was 66 years 
compared to 60 years in Caucasian males. Females of African ethnicity were 10 years older than males of 
African ethnicity (61 vs. 51 years). There were 6 patients of mixed ancestry (2,3%), of which 5 were male 
(median age 53 years), and only 2 Indian patients (0,8%), both males with a median age of 50 years. The 
demographic data for patients presenting with unstable angina/NSTEMI/STEMI is demonstrated in Table 
3-4. 
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Table 3-4: Demographic data of patients presenting with ACS. 
 1994 (n=261) 2014 (n=338) 
 Male Female Male Female 
 n Age n Age n Age n Age 
Unstable angina         
African ethnicity 2 49 0 - 7 60 2 56 
Caucasian 94 61 51 66 34 64 19 61 
Mixed race 2 58 1 67 3 63 6 63 
Indian 1 44 0 - 0 - 0 - 
NSTEMI         
African ethnicity 2 58 1 61 7 63 5 65 
Caucasian 10 63 2 50 59 63 16 66 
Mixed race 1 51 0 - 9 65 12 61 
Indian 0 - 0 - 4 48 2 55 
STEMI         
African ethnicity 2 63 6 46 30 54 15 60 
Caucasian 61 56 22 69 50 60 14 60 
Mixed race 2 59 0 - 20 56 14 61 
Indian 1 56 0 - 8 38 2 62 
 
ACS 2014 (n=338) 
The majority of ACS patients had STEMI (n=153; 33,3%) and NSTEMI was almost a quarter of the group 
(n=114; 24,8%). Unstable angina was diagnosed in 71 patients (15,4%). 
Non-modifiable risk factors 
Almost two thirds were male (n=231; 68,3%) and had a slightly younger median age (60 years) than females 
(62 years). The largest ethnic group were Caucasians (n=192; 56,8%). Patients of African ethnicity (n=66; 
19,5%) and mixed ancestry (n=64; 18,9%) were the second largest groups, and Indian patients (n=16; 4,7%) 
were the smallest group. Both Caucasian males and females had a median age of 62 years. Males of African 
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ethnicity presented 6 years younger than females of African ethnicity (55 vs. 61 years). Of the mixed ancestry 
group exactly half (50%) was male (n=32) and their median age was slightly lower (59 years) than those of 
mixed ancestry females (61 years). The majority of Indian patients were male (n=12; 75%) with a much 
lower median age of 41 years, as compared to Indian females (60 years). The demographic data for patients 
presenting with unstable angina/NSTEMI/STEMI is demonstrated in Table 3-4. 
ACS comparison 2014 vs. 1994 (1994, n=261; 2014, n=338) 
ACS increased significantly over the study period (p<0,0001) and this can be attributed to a notable increase 
in both NSTEMI (p<0,0001) and STEMI (p<0,0001). Unstable angina decreased significantly over the study 
period (p<0,0001). 
There was a significant increase in the number of African patients who experienced STEMI over the study 
period (p<0,0001) while unstable angina and NSTEMI remained the same. There was a substantial decrease 
in Caucasian patients who had ACS (p=0,0015). While NSTEMI increased significantly in Caucasian 
patients (p<0,0001), unstable angina in this group decreased significantly (p<0,0001). 
A significant finding was that ACS females presented 4 years earlier in 2014 than those in 1994 (1994 median 
age = 66 years vs. 2014 median age = 62 years) (p=0,0031, 95% CI 1,3941; 6,7202). This trend was 
predominantly demonstrated in Caucasian females only (1994 median age = 66 years vs. 2014 median age = 
62 years; p=0,04811, 95% CI 0,0276; 6,5743) while Caucasian males tended to be about two years older 
(1994 median age = 60 years vs. 2014 median age = 62 years; p=0,0260, 95% CI -5,6230; -3,602). 
The age of females with STEMI decreased significantly from 1994 (median age 69 years) to 2014 (median 
age 60 years) (p=0,0119; 95% CI 1,4195; 10,8305). A similar pattern was observed in females with unstable 
angina, who were six years younger in 2014 (median age 60 years) compared to 1994 (median age 66 years) 
(p=0,0269, 95% CI 0,5800; 9,1978). 
Caucasian females with NSTEMI was markedly older in 2014 (median age 66 years) than in 1994 (median 
age 50 years) (p<0,0001, 95% CI -19,7368; -12,8882), while those with STEMI became younger (1994 
median age = 69 years vs. 2014 median age = 60 years, p=0,0269; 95% CI 0,9640; 14,6464). Subgroup 
analysis did not reveal any other significant demographic changes as some sample sizes were too small for 
statistical analysis. 
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This is the first study in central SA describing the profile of patients with CAD based on cardiac angiographic 
findings. Results of this study showed significant changes in the profile of patients who presented with CAD 
at UAH over a twenty-year period. Numbers of patients with CAD increased in African and mixed ethnicity 
patients. ACS increased significantly over time. STEMI increased significantly in patients of African 
ethnicity whilst NSTEMI was significantly increased in Caucasian patients. 
Patients of African and mixed race with CAD increased more than five-fold over the study period (Figure 
3-1). CAD was predominantly seen in males, similar to other studies (Ford & Capewell, 2007; Bhatnagar et 
al., 2015; The EUGenMed Cardiovascular Clinical Study Group et al., 2016; Masina et al., 2016). Caucasian 
males with CAD were slightly older in 2014 (median age = 63 years) than in 1994 (median age = 61 years). 
This study did not assess the reasons for these changes but the authors speculate that it could be due to the 
fact that more African individuals are exposed to modifiable risk factors during urbanization as predicted by 
Mayosi and others (Yusuf et al., 2001b; Steyn et al., 2005; Alberts et al., 2005; Department of Health et al., 
2007; Sliwa et al., 2008; Tibazarwa et al., 2009; Mayosi et al., 2009; Gersh et al., 2010; Pretorius et al., 2011; 
Mayosi et al., 2012; Onen, 2013). 
In both years most CAD patients came from the Free State and almost half of these came from the Mangaung 
district, the largest metropolitan area in central SA. The second largest referral district was the Northern 
Cape. Urbanization presents an increased risk for unhealthy lifestyles and is another plausible explanation 
for our study findings (Yusuf et al., 2001a; Smith et al., 2012; Sliwa et al., 2016). Due to the fact that CAD 
often takes years to develop, the steady increase in overall life expectancy of South Africans (up from 52,1 
years in 2003 to 59,6 years in 2013) (Stats SA, 2013) is an added factor in more patients presenting with 
CAD. 
Females with CAD who had three vessel involvement presented at a younger age (median age = 64 years) in 
2014 as compared to 1994 (median age = 69 years). However, this trend was only demonstrated in Caucasian 
females (1994 median age = 70 years vs. 2014 median age = 64 years) while Caucasian males were one year 
older (1994 median age = 61 years vs. 2014 median age = 62 years). 
ACS showed a significant increase in 2014 compared to 1994. Our findings are in agreement with the 
ACCESS (Acute Coronary Events – a Multinational Survey of Current Management Strategies) registry 
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which showed that (from January 2007 to January 2008) 10,7% of ACS patients in SA were of mixed  race 
and 5,9% were African (Schamroth, 2012). This seem to indicate that there is an upward trend in African 
patients with ACS. 
In 2014 almost a third of ACS patients who presented with STEMI were of African ethnicity. By contrast, 
NSTEMI increased significantly in Caucasian patients over the same period. Our results compare favourably 
to the rise in STEMI and NSTEMI as observed in other countries. In metropolitan France acute myocardial 
infarction (STEMI + NSTEMI) cases rose from 15 per 104 (10 000) in 2009 to 19.8 per 104 in 2014 for men 
and 6.3 per 104 to 8 per 104 for women (Pinaire et al., 2019). Singapore saw an  increase in STEMI incidence 
among Malay patients from 97 per 100,000 population in 2007 to 114 per 100,000 population in 2014 (Zheng 
et al., 2019). In Europe and the Mediterranean, the Euro Heart Survey on Acute Coronary Syndromes (EHS-
ACS-II) reported a 5% rise (from 42% in 2000 to 47% in 2004) in STEMI among ACS patients 
(Mandelzweig et al., 2006). 
In our study STEMI in African patients showed a significant increase of 20,9% compared to 1994. A similar 
trend has been observed in other developing countries. From 2007 to 2009, in Kerala (India), more patients 
presented with STEMI (37%) than NSTEMI (31%), or unstable angina (32%, p< 0,001) (Mohanan et al., 
2013). The same phenomenon was seen in Nairobi (Kenya) from 2008 to 2010 where 56% of ACS patients 
had STEMI and 44% NSTEMI/unstable angina (Shavadia et al., 2012) . In Durban, SA, 2008 to 2012, a 
staggering 83% of acute myocardial infarctions among black African patients were caused by STEMI and 
only 17% by NSTEMI (Masina et al., 2016). 
A possible explanation for the rise in STEMI may be difficulties and delays in referrals from rural areas and 
late patient presentation with subsequent worsening of symptoms from angina to STEMI. Delayed referrals 
may be due to the false assumption that STEMI infrequently occurs in the African population and is therefore 
not expected to be of imminent importance. Patients in some communities may be ignorant of the fact that 
chest pain can be caused by myocardial ischemia. Patients therefore only present to a medical facility once 
symptoms worsen. In a multicentre registry study done in India long pre-hospital delays were due to lack of 
awareness of symptoms of ACS, consulting local practitioners, and long traveling time (Negi et al., 2016). 
Similar to this, one SA study showed that misinterpretation of symptoms as being non-cardiac in nature was 
the most common reason for pre-hospital delays, and in some cases it took more than ten hours for the patient 
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to arrive at the hospital (Meel & Gonçalves, 2016). Other reasons for delays include difficulties in ECG 
interpretation, problematic referral methods and lack of transport (Maharaj et al., 2012; Stassen, 2018). 
The decrease in Caucasian patients who had ACS (p=0,0015) can be attributed to several factors such as 
access to private medical aid (Department of Health et al., 2007; Mayosi et al., 2012; Statistics South Africa, 
2014), dissatisfaction with the public healthcare system (Shisana et al., 2013) and therefore preferring to be 
treated in a private facility (Lillie-Blanton et al., 2002). It is also known that Caucasian South Africans are 
sufferers of familial hypercholesterolemia (Steyn et al., 1996; Department of Health et al., 2007; Firth & 
Marais, 2008; Delport, 2009; Blom, 2011) and it is probable that increasing numbers of Caucasians are on 
primary prevention therapies like statins and aspirin (Biccard et al., 2006; Bouhairie & Goldberg, 2015; Klug 
et al., 2015), leading to a decrease in ACS events. 
NSTEMI increased significantly in Caucasian patients (p<0,0001) while unstable angina in this group 
decreased significantly (p<0,0001). This change seems to be reciprocal in nature and the data must be 
interpreted with caution because the distinction between unstable angina and NSTEMI is complex and 
involves multiple test results, patient history as well as risk stratification based on clinical presentation 
(Kleinschmidt, 2006). Due to the more modern use of high-sensitivity biomarkers to diagnose NSTEMI it is 
plausible that many patients previously diagnosed with unstable angina could have been reclassified as 
having NSTEMI (Goodman et al., 2006). Several studies reported similar findings where the incidence of 
NSTEMI and unstable angina changed due to changing myocardial infarction definitions and criteria 
(Falahati et al., 1999; Alpert et al., 2000; Kontos et al., 2003; Abildstrom et al., 2005; Thygesen et al., 2007; 
Nielsen et al., 2007; Parikh et al., 2009; Myerson et al., 2009; Yeh et al., 2010; Roger et al., 2010; Reichlin 
et al., 2012; D’Souza et al., 2015). 
A significant finding was that ACS females presented 4 years earlier in 2014 than those in 1994 (1994 median 
age = 66 years vs. 2014 median age = 62 years) (p=0,0031, 95% CI 1,3941; 6,7202). This was mainly 
attributed to the age of females with STEMI that decreased significantly from 1994 (median age 69 years) to 
2014 (median age 60 years) (p=0,0119; 95% CI 1,4195; 10,8305). From 2002 to 2014, the median age of 
females with STEMI significantly decreased from 73.7 (57.9–81.8) to 69.6 years (57.0–82.4) in France, even 
though there was no significant variation in the prevalence of risk factors (Loyeau et al., 2018). It should be 
noted that the median age of ACS females found in our study is about ten years younger. This is concerning 
© Central University of Technology, Free State
M.A.S.E. Bester 




since it seems to indicate that there is an increase in the prevalence of risk factors for CAD in central SA, 
especially among females. This strongly supports the need for further research. 
Caucasian females with NSTEMI was markedly older in 2014 (median age 66 years) than in 1994 (median 
age 50 years) whilst those with STEMI became younger (1994 median age = 69 years vs. 2014 median age 
= 60 years. A similar NSTEMI trend was observed in Taiwan (Yang et al., 2012). Females with unstable 
angina were six years younger in 2014 (median age 60 years) as compared to 1994 (median age 66 years). 
In spite of the important increase in ACS, the pattern of CAD (one, two or three vessels affected) did not 
change significantly over the study period. Additionally, the difference in treatment modalities between the 
two eras reflect that there was a shift towards the more modern use of PTCA and stent as opposed to using 
PTCA alone in the past. 
Limitations 
Although this is a single-centre retrospective study, UAH is the sole public referral institution for the region 
as described and therefore the vast majority of public sector patients with CAD will be seen at this institution. 
Historical data was used and therefore strict definitions for NSTEMI, STEMI and unstable angina were used 
to ensure accuracy of data in the absence of high-sensitivity cardiac biomarker assays. Although all 
catheterization data was available, a large number of clinical files of 1994 could not be found and this 
explains the lack of family history and treatment data. However, catheterization data was verified as 
described in the methods section. Subgroup analysis was performed (based on age, gender and ethnicity) 
even though some subgroup sample sizes were small, therefore results should be interpreted accordingly. 
This study assessed the patient profiles and emphasizes the need for research into modifiable risk factors in 
central SA. The incidence in the African population may be underestimated by this study, as the most affluent 
African patients are at the highest risk and have medical insurance: they present to the private healthcare 
sector. Therefore, this study also highlights the need for research on this subject in the private sector. 
By generating local data this study serves as an important first step in demonstrating an epidemiological 
change in public sector CAD patients in central SA. These findings are crucial to the planning of public 
health and demonstrates the urgent need for aggressive risk factor control as well as education regarding 
CAD prevention. 
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Results of the study showed an epidemiological change in CAD in the public sector of central SA with CAD 
increasing in patients of African and mixed ethnicity. ACS has risen significantly over time with females 
presenting at a significantly younger age. STEMI became the most important presenting condition in patients 
of African ethnicity whilst NSTEMI increased in Caucasian patients. These findings have important 
implications for central SA public sector patients presenting with chest pain – the risk of STEMI in patients 
of African ethnicity is increasing and should not be ignored by clinicians. 
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Appendix C: Glossary 
A 
Term Definition 
Absent Not present at a usual or expected place. 




A chronic, potentially life-threatening condition caused by the 
Human Immunodeficiency Virus (HIV). By damaging the immune 
system, HIV interferes with the body's ability to fight the organisms 
that cause disease. 
Acute Severe but of short duration. 
Acute coronary 
syndrome 
An acute ischemic insult to the myocardium resulting from sudden 
reduction in coronary blood flow. ECG findings categorizes patients 
into two major subdivision of major diagnostic and therapeutic 
consequences: ST-elevation ACS (generally reflects an acute total 
coronary occlusion) or non-ST elevation ACS (Patients with acute 
chest pain but no persistent ST-segment elevation). Non-ST elevation 
ACS is further classified either unstable angina or NSTEMI. 
Adhesion molecules 
Proteins located on the cell surface involved in binding with other 
cells or with the extracellular matrix (ECM) in the process called cell 
adhesion. In essence, cell adhesion molecules help cells stick to each 
other and to their surroundings. 
Adipose tissue 
An anatomical term for loose connective tissue composed of 
adipocytes. Its main role is to store energy in the form of fat, although 
it also cushions and insulates the body. Also called fat. 
Adrenergic 
Relating to or denoting nerve cells in which adrenaline, 
noradrenaline, or a similar substance acts as a neurotransmitter. 
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Adult Fully developed and mature. 
African-American 
Heart Failure (a-HeFT) 
A clinical trial that was performed to evaluate treatment with a fixed 
dose of isosorbide dinitrate (a medication used for heart failure, 
oesophageal spasms, and to treat and prevent chest pain caused by 
inadequate blood flow to the heart) plus hydralazine (a medication 
used to treat high blood pressure and heart failure) compared with 
placebo among black patients with advanced heart failure. 
African-American 
Study of Kidney 
Disease and 
Hypertension (AASK) 
The African American Study of Kidney Disease and Hypertension 
study (AASK Trial) was a multi-centre, randomized clinical trial that 
investigated the effects of blood pressure (BP) control and the use of 
specific antihypertensive regimens on the progression of chronic 
kidney disease (CKD). The study was designed to address the high 
incidence of CKD in African Americans with hypertension. 
Afrikaans 
A language developed from 17th century Dutch that is one of the 
official languages of South Africa. 
Age 
The length of an existence extending from the beginning to any given 
time. 
Age-standardised 
In epidemiology and demography, age adjustment, also called age 
standardization, is a technique used to allow populations to be 
compared when the age profiles of the populations are quite different. 
Aggregation The formation of a number of things into a cluster. 
Alcohol 
A colourless volatile flammable liquid which is produced by the 
natural fermentation of sugars and is the intoxicating constituent of 
wine, beer, spirits, and other drinks, and is also used as an industrial 
solvent and as fuel. 
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American College of 
Cardiology Foundation 
(ACCF) 
The American College of Cardiology (ACC), based in Washington, 
D.C., is a non-profit medical association established in 1949. It 
bestows credentials upon cardiovascular specialists who meet its 
qualifications. Education is a core component of the college, which 




The American Heart Association is a non-profit organization in the 
United States that funds cardiovascular medical research, educates 
consumers on healthy living and fosters appropriate cardiac care in 
an effort to reduce disability and deaths caused by cardiovascular 
disease and stroke. 
Anastomosis 
A connection made surgically between adjacent blood vessels, parts 
of the intestine, or other channels of the body. 
Angina pectoris 
Severe constricting pain or sensation of pressure in the chest, often 
radiating from the precordium to a shoulder (usually left) and down 
the arm, resulting from ischemia of the heart muscle usually caused 




Any of a group of antihypertensive drugs (such as captopril) that relax 
arteries and promote renal excretion of salt and water by inhibiting 
the activity of angiotensin converting enzyme. 
Antiaggregant See Antiplatelet drug. 
Anticoagulant 




Treatment to Prevent 
Heart Attack 
(ALLHAT) Trial 
A clinical trial performed to determine if the combined incidence of 
nonfatal myocardial infarction and coronary heart disease death 
differs between diuretic-based and each of three alternative 
antihypertensive pharmacological treatments. 
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A member of a class of pharmaceuticals that decrease platelet 
aggregation and inhibit thrombus formation. They are effective in the 




Medications for the treatment of infection by retroviruses, primarily 
HIV. Different classes of antiretroviral drugs act at different stages of 
the HIV life cycle. Combination of several (typically three or four) 
antiretroviral drugs is known as Highly Active Anti-Retroviral 
Therapy (HAART). 
Aorta 
The main artery of the body, supplying oxygenated blood to the 
circulatory system. In humans it passes over the heart from the left 
ventricle and runs down in front of the backbone. 
Aortic aneurysm 
An enlargement (dilation) of the aorta to greater than 1.5 times 
normal size. They usually cause no symptoms except when ruptured. 
Occasionally, there may be abdominal, back, or leg pain. They are 
most commonly located in the abdominal aorta but can also be 
located in the thoracic aorta. 
Aortic incompetence 
Also known as aortic regurgitation (AR), is the leaking of the aortic 
valve of the heart that causes blood to flow in the reverse direction 
during ventricular diastole, from the aorta into the left ventricle. 
Aortic valve 
The semilunar valve separating the aorta from the left ventricle that 
prevents blood from flowing back into the left ventricle. 
Apartheid 
A policy or system of segregation or discrimination on grounds of 
race. 
Artery 
A relatively thick-walled, muscular, pulsating blood vessel 
conveying blood away from the heart. With the exception of the 
pulmonary and umbilical arteries, the arteries contain red or 
oxygenated blood. 
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Made or produced by human beings rather than occurring naturally, 
especially as a copy of something natural. 
Aspirin 
A synthetic compound used medicinally to relieve mild or chronic 
pain and to reduce fever and inflammation, usually taken in tablet 
form. 
Atheroma 
The lipid deposits in the intima of arteries, producing a yellow 
swelling on the endothelial surface; a characteristic of 
atherosclerosis. 
Atherosclerosis 
Hardening of the arteries characterized by irregularly distributed lipid 
deposits in the intima of large and medium-sized arteries, causing 
narrowing of arterial lumens and proceeding eventually to fibrosis 
and calcification. Lesions are usually focal and progress slowly and 
intermittently. Limitation of blood flow accounts for most clinical 
manifestations, which vary with the distribution and severity of 
lesions. 
Atherosclerosis Risk in 
Communities (ARIC) 
study 
A multi-site, prospective, biracial cohort study that was designed to 
investigate the etiology and clinical outcomes of atherosclerosis. A 
total of 15,792 middle-aged (45–64 years) men and women were 
enrolled from four U.S. communities. The study was performed 
between 1987 and 2013. 
Atrial fibrillation (AF) 
An abnormal and irregular heart rhythm in which electrical signals 
are generated chaotically throughout the upper chambers (atria) of the 
heart. AF can lead to blood clots, stroke, heart failure and other heart-
related complications. 
Atrial flutter (AFL) 
Well-organized but overly rapid contractions of the atrium of the 
heart (usually at a rate of 250-350 contractions per minute). Flutter 
refers to a rapid vibration or pulsation. The difference between flutter 
and fibrillation is that flutter is well organized while fibrillation is not. 
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Attenuate Reduce the force, effect, or value of. 
Autopsy 
A post-mortem examination to discover the cause of death or the 
extent of disease. 
aVF 
A unipolar ECG lead called augmented Vector Foot (aVF) that 
measures the electrical activity of the heart through a positive 
electrode placed on the foot of the patient. 
aVL 
A unipolar ECG lead called augmented Vector Left (aVL) that 
measures the electrical activity of the heart through a positive 




A circumstance or obstacle that keeps people or things apart or 
prevents communication or progress. 
Beta-blocker 
Any of a class of drugs which prevent the stimulation of the 
adrenergic receptors responsible for increased cardiac action, used to 
control heart rhythm, treat angina, and reduce high blood pressure. 
Biomarker 
A naturally occurring molecule, gene, or characteristic by which a 
particular pathological or physiological process, disease, etc. Can be 
identified. 
Blood pressure (BP) 
The pressure of the blood in the circulatory system, often measured 
for diagnosis since it is closely related to the force and rate of the 
heartbeat and the diameter and elasticity of the arterial walls. 
Body mass index 
(BMI) 
An approximate measure of whether someone is over- or 
underweight, calculated by dividing their weight in kilograms by the 
square of their height in metres. 
Brachial Relating to the arm or an arm-like structure. 
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The British Broadcasting Corporation is a British public service 
broadcaster. Its headquarters are at Broadcasting House in 
Westminster, London, and it is the world's oldest national 
broadcasting organisation and the largest broadcaster in the world by 
number of employees. 




A unit of energy: the energy needed to raise the temperature of 1 
kilogram of water through 1 °C, equal to one thousand small calories 
(cal) and often used to measure the energy value of foods. 
Carbon monoxide 
A colourless, odourless toxic flammable gas formed by incomplete 
combustion of carbon. 
Cardiac catheterization 
Process whereby a thin flexible catheter is introduced into an artery 
and advanced into the heart for diagnosis or therapy. 
Cardiogenic shock 
A medical emergency resulting from inadequate blood flow due to 
the dysfunction of the ventricles of the heart. 
Cardiomyopathy 
Any structural or functional disease of heart muscle that is marked 
especially by enlargement of the heart, by hypertrophy of cardiac 
muscle, or by rigidity and loss of flexibility of the heart walls and that 
may be idiopathic or attributable to a specific cause (such as heart 
valve disease, untreated high blood pressure, or viral infection). 
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This refers to the whole circulatory system: the heart, the systemic 
circulation (the arteries and veins of the body) and the pulmonary 
circulation (the arteries and veins of the lungs). Blood circulates 
throughout the cardiovascular system, bringing oxygen and nutrients 
to the tissues and removing carbon dioxide and other waste products. 
Catheter A flexible tube inserted through a narrow opening into a body cavity. 
Cathlab 
A catheterization laboratory or cathlab is an examination room in a 
hospital or clinic with diagnostic imaging equipment used to visualize 
the arteries of the heart and the chambers of the heart and treat any 
stenosis or abnormality found. 
Cell 
The smallest structural and functional unit of an organism, which is 
typically microscopic and consists of cytoplasm and a nucleus 
enclosed in a membrane. 
Cerebrovascular Relating to the brain and its blood vessels. 
Child 
A young human being below the age of puberty or below the legal 
age of majority. 
Cholesterol 
A lipid that is an important constituent of body cells and is widely 
distributed throughout the body. It is especially abundant in the brain, 
nervous tissue, adrenal glands and skin. A high blood-cholesterol 
level – that is, one over 6 mmol per litre or 238 mg per 100 ml – is 
undesirable as there appears to be a correlation between a high blood 
cholesterol and atheroma, the form of arterial degenerative disease 
associated with coronary thrombosis and high blood pressure. 
Cholesterol exists in three forms in the blood: high-density 
lipoproteins (HDL) which are believed to protect against arterial 
disease; a low-density version (LDL); and a very low-density type 
(VLDL) – these latter two being risk factors. 
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A thread-like structure of nucleic acids and protein found in the 
nucleus of most living cells, carrying genetic information in the form 
of genes. 
Chronic Persisting for a long time or constantly recurring. 
Circumflex artery 
(LCX) 
Fully titled as the circumflex branch of the left coronary artery, is an 
artery that branches off from the left coronary artery to supply 
portions of the heart with oxygenated blood. The circumflex artery 
itself divides into smaller arterial systems. 
City A large town. 
Clinic 
An establishment or hospital department where outpatients are given 
medical treatment or advice, especially of a specialist nature. 
Clopidogrel 
An inhibitor of platelet aggregation, used in the form of the bisulphate 
salt to prevent formation of thrombi and prevent myocardial 
infarction, stroke, and vascular death in patients with atherosclerosis. 
Sold as the brand name Plavix, among others. 
Cobalt-chromium 
A metal alloy of cobalt and chromium used in many surgical 
implants. The metal has been a preferred material for implant 
surgeries, and in particular total hip replacement, because it is 
tolerated well by the body. 
Community 
A group of people living in the same place or having a particular 
characteristic in common. 
Connective tissue 
Tissue that connects, supports, binds, or separates other tissues or 
organs, typically having relatively few cells embedded in an 
amorphous matrix, often with collagen or other fibres, and including 
cartilaginous, fatty, and elastic tissues. 
Consequence A result or effect, typically one that is unwelcome or unpleasant. 
Constitutional Relating to an established set of principles governing a state. 
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Constrict Make narrower, especially by encircling pressure. 
Contrast medium 
A substance introduced into a part of the body in order to improve the 
visibility of internal structures during radiography. 
Coronary 
A term applied to any structure in the body encircling an organ in the 
manner of a crown. Most commonly it is used in reference to the 
coronary arteries, through which blood is delivered to the muscle of 
the heart. 
Coronary angiography 
Imaging of the circulation of the myocardium by injection of contrast 
medium, usually by selective catheterization of each coronary artery. 
Coronary artery bypass 
graft (CABG) 
A surgical procedure in which damaged sections of the coronary 
arteries are replaced with new articular of venous graftings to increase 
rate of cardiac blood flow. 
C-reactive protein 
(CRP) 
An annular (ring-shaped), pentameric protein found in blood plasma, 
whose levels rise in response to inflammation. 
Creatine-kinase MB 
(CK-MB) 
A cardiac marker used to assist diagnoses of an acute myocardial 
infarction. A ck-mb blood test measures the blood level of ck-mb 
(creatine kinase-muscle/brain), the bound combination of two 
variants (isoenzymes CKM and CKB) of the enzyme 
phosphocreatine kinase. 
Critical Crucial, judged, analysed, at a turning point or on the verge of a crisis. 
Crude In a natural or raw state; not yet processed or refined. 
Culprit The cause of a problem or defect. 
Cytokine 
Any of a number of substances, such as interferon, interleukin, and 
growth factors, which are secreted by certain cells of the immune 
system and have an effect on other cells. 
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Death The end of the life of a person or organism. 
Debilitating Tending to weaken something. 
Decade A period of ten years. 
Democracy Control of an organization or group by the majority of its members. 
Demographics 
Statistical data relating to the population and particular groups within 
it. 
Department of Health 
(DOH) 
The executive department of the South African government that is 
assigned to health matters. 
Deteriorate Become progressively worse. 
Diabetes mellitus 
A group of metabolic diseases characterized by hyperglycaemia 
resulting from defects in insulin secretion, insulin action, or both. 
Diagnosis 
The identification of the nature of an illness or other problem by 
examination of the symptoms. 
Diameter 
A straight line passing from side to side through the centre of a body 
or figure, especially a circle or sphere. 
Diastole 
The phase of the heartbeat when the heart muscle relaxes and allows 
the chambers to fill with blood. 
Disease 
A disorder of structure or function in a human, animal, or plant, 
especially one that produces specific symptoms or that affects a 
specific location and is not simply a direct result of physical injury. 
Disparity A great difference. 
Distal 
Situated away from the centre of the body or from the point of 
attachment. 
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Refers to the effects of treatment with a drug. If the effects change 






Graphic record of the heart's integrated action currents obtained with 
the electrocardiograph displayed as voltage changes over time. 
Empirical 
Based on, concerned with, or verifiable by observation or experience 
rather than theory or pure logic. 
Endocarditis Inflammation of the endocardium. 
Endocardium 
The thin, smooth membrane which lines the inside of the chambers 
of the heart and forms the surface of the valves. 
Endogenous Having an internal cause or origin. 
Endothelium 
The tissue which forms a single layer of cells lining various organs 
and cavities of the body, especially the blood vessels, heart, and 
lymphatic vessels. It is formed from the embryonic mesoderm. 
Epicardium 
A serous membrane that forms the innermost layer of the 
pericardium, attached to the muscles of the wall of the heart. 
Epidemic 
A widespread occurrence of a disease in a community at a particular 
time. 
Epidemiology 
The study of disease as it affects groups of people. Originating in the 
study of epidemics of diseases like cholera, plague and smallpox, 
epidemiology is an important discipline which contributes to the 
control not only of infectious diseases but also of conditions such as 
heart disease and cancer. Their distributions in populations can 
provide important pointers to possible causes. 
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Estimate Roughly calculate or judge the value, number, quantity, or extent of. 
Ethnicity/ethnic group 
A social group characterized by a distinctive social and cultural 
tradition maintained from generation to generation, a common history 
and origin, and a sense of identification with the group; members 
have distinctive features in their way of life, shared experiences, and 
often a common genetic heritage; these features may be reflected in 
their experience of health and disease. 




A study performed to examine the management of acute coronary 
syndromes (ACS) in Europe and the Mediterranean basin, and to 
compare adherence to guidelines with that reported in the first Euro 
Heart Survey on ACS (EHS-ACS-I), 4 years earlier. 
European Society of 
Cardiology (ESC) 
A non-profit knowledge-based professional association that 
facilitates the improvement and harmonisation of standards of 
diagnosis and treatment of cardiovascular diseases. 
Exertion Physical or mental effort. 
Extent 




Familial Relating to or occurring in a family or its members. 
Familial 
hypercholesterolemia 
An inherited condition that results in high levels of low-density 
lipoprotein cholesterol and increased risk of premature 
cardiovascular disease in men and women. 
Family history 
Information concerning the disorders suffered by the direct relatives 
of a patient. 
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Farming The activity or business of growing crops and raising livestock. 
Fat 
A natural oily substance occurring in animal bodies, especially when 
deposited as a layer under the skin or around certain organs. 
Female 
Of or denoting the sex that can bear offspring or produce eggs, 
distinguished biologically by the production of gametes (ova) which 
can be fertilized by male gametes. 
Femoral Of or relating to the femur or thigh. 
Fibrin 
An insoluble protein formed from fibrinogen during the clotting of 
blood. It forms a fibrous mesh that impedes the flow of blood. 
Fibrous Consisting of or characterized by fibres. 
First degree relative A person's parent. 
Fluctuation An irregular rising and falling in number or amount; a variation. 
Fluoroscopy 
Fluoroscopy is an imaging technique that uses X-rays to obtain real-
time moving images of the interior of an object. 
Free radical 
An uncharged molecule (typically highly reactive and short-lived) 
having an unpaired valency electron. 
G 
Term Definition 
Gender The state of being male or female. 
Genetic Relating to genes or heredity. 
Glycoxidation The oxidation of sugars, glycoproteins or glycolipids. 
Gold A yellow precious metal. 
Graft A piece of living tissue that is transplanted surgically. 
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An Indo-Aryan language native to the Indian state of Gujarat. It is 
part of the greater Indo-European language family. 
H 
Term Definition 
Health and Ageing in 
Africa (HAALSI) study 
A highly interdisciplinary study aiming to investigate over time the 
social, economic and biological risks for chronic health conditions, 
whether infectious or non-infectious, in a random sample of adults 40 
years and older in the Agincourt sub-district. HAALSI focuses on 
cardio metabolic disease, HIV/AIDS, cognitive functioning and 
dementias, multi-morbidity and their social and economic correlates, 
as these are of special interest in South Africa as it undergoes 





In the fields of demographics and public health, a health and 
demographic surveillance system (HDSS), gathers longitudinal 
health and demographic data for a dynamic cohort of the total 
population in a specified geographic area. An HDSS is created by 
first executing a census of households in the area as a baseline, 
followed by regular visits to each household to gather health and 
demographic data. The cohort is dynamic in that members are added 
through birth or immigration and members are subtracted through 




The Health Sciences Research Ethics Committee (HSREC) is 
responsible for managing and facilitating the ethical and governance 
review processes for all health research. This involves coordinating 
scientific and ethical review of research. In addition, the HSREC is 
responsible for compliance governance, including research 
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monitoring, the provision of researcher support and advice, and risk 
management. 
Heart 
A hollow muscular pump with four cavities, each provided at its 
outlet with a valve, whose function is to maintain the circulation of 
the blood. The two upper cavities are known as atria, and the two 
lower ones as ventricles. 
Heart failure 
Inadequacy of the heart so that as a pump it fails to maintain the 
circulation of blood, with the result that congestion and oedema 
develop in the tissues. 
High density 
lipoprotein (HDL) 
A class of lipoproteins of relatively high density, the main function 
of which is to transport cholesterol from the tissues to the liver for 
excretion. 
Homocysteine 
An amino acid which occurs in the body as an intermediate in the 
metabolism of methionine and cysteine. 
Hormones 
A regulatory substance produced in an organism and transported in 





A lentivirus that causes HIV infection and over time Acquired 
Immunodeficiency Syndrome. 
Hypercholesterolemia An excess of cholesterol in the bloodstream. 
Hyperglycaemia 
An excess of glucose in the bloodstream, often associated with 
diabetes mellitus. 
Hypertension Abnormally high blood pressure. 
Hypertensive heart 
disease 
The cardiomyopathy that results from the response of the 
myocardium to the biomechanical stress imposed on the left ventricle 
by progressively increasing arterial pressure. 
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Hypertriglyceridemia The presence of an excess of triglycerides in the blood. 
Hypotheses 
A supposition or proposed explanation made on the basis of limited 




The occurrence, rate, or frequency of a disease, crime, or other 
undesirable thing. 
INDEPTH 
A global network of health and demographic surveillance systems 
(HDSS’s) that provide a more complete picture of the health status of 
communities. This network collects data from whole communities 
over extended time periods, thereby reflecting health and population 
problems in low- and middle-income countries (LMIC’s) 
Industrialize Develop industries (in a country or region) on a wide scale. 
Infarction 
An area of tissue necrosis caused by impairment of arterial or venous 
blood supply due to mechanical factors (e.g., emboli, thrombi) or to 
blood pressure alterations. 
Infectious 
Liable to be transmitted to people, organisms, etc. Through the 
environment. 
Inflammation 
A localized physical condition in which part of the body becomes 
reddened, swollen, hot, and often painful, especially as a reaction to 
injury or infection. 
Inherit 
Derive (a quality, characteristic, or predisposition) genetically from 
one's parents or ancestors. 
Inhibit Hinder, restrain, or prevent (an action or process). 
Insight An accurate and deep understanding. 
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A hormone produced in the pancreas by the islets of Langerhans, 
which regulates the amount of glucose in the blood. The lack of 
insulin causes a form of diabetes. 
Intermediate Coming between two things in time, place, character, etc. 
Intervention Action taken to improve a medical disorder. 
Intima 
The innermost coating or membrane of a part or organ, especially of 
a vein or artery. 
Intramural Situated within the wall of a hollow organ or a cell. 
Intravenous (IV) Existing or taking place within, or administered into, a vein or veins. 
Ischemia 
Local loss of blood supply due to mechanical obstruction (mainly 
arterial narrowing or disruption) of the blood vessel (Stedman’s 




Ischaemia and infarction with subsequent loss of contractility and 
remodelling of the heart. 
Ischemic Heart Disease 
(IHD) 
A heart disease that involves the reduction of blood flow to the heart 
muscle due to build-up of plaque in the arteries of the heart. 
K 
Term Definition 
Kingdom A country, state, or territory ruled by a king or queen. 
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One of two major branches of the left coronary artery. It runs down 
the anterior interventricular groove, and it supplies blood to the 
anterior walls of the right and left ventricles and to the 
interventricular septum. Occlusion of this artery is often called the 




Left ventricular ejection fraction (LVEF) is the measurement of how 
much blood is being pumped out of the left ventricle of the heart (the 
main pumping chamber) with each contraction. 
Lentivirus 
A genus of retroviruses that cause chronic and deadly diseases 
characterized by long incubation periods, in the human and other 
mammalian species. The best-known lentivirus is the Human 
Immunodeficiency Virus (HIV), which causes Acquired 
Immunodeficiency Syndrome (AIDS.) 
Leukocyte 
A colourless cell which circulates in the blood and body fluids and is 
involved in counteracting foreign substances and disease; a white 
(blood) cell. There are several types, all amoeboid cells with a 
nucleus, including lymphocytes, granulocytes, and monocytes. 
Life expectancy The average period that a person may expect to live. 
Lifespan 
The length of time for which a person or animal lives or a thing 
functions. 
Linear 
Progressing from one stage to another in a single series of steps; 
sequential. 
Lipid 
Any of a class of organic compounds that are fatty acids or their 
derivatives and are insoluble in water but soluble in organic solvents. 
They include many natural oils, waxes, and steroids. 
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Relating to Lithuania (a country and the southernmost of Europe’s 




Countries which are defined as low-income economies ($1,005 or 
less gross national income per capita) or as lower-middle-income 
economies ($1,006 to $3,955 gross national income per capita), as 
defined by The World Bank Group. 
Low density lipoprotein 
(LDL) 
A class of lipoproteins of relatively low density, the main function of 




Of or denoting the sex that produces gametes, especially 
spermatozoa, with which a female may be fertilized or inseminated 
to produce offspring. 
Markedly To an extent which is clearly noticeable; significantly. 
Menopause 
The period in a woman's life (typically between the ages of 45 and 
50) when menstruation ceases. 
Mesh An interlaced structure. 
Metabolize Process (a substance) by metabolism. 
Microvascular Relating to the smallest blood vessels. 
Mismatch A failure to correspond or match; a discrepancy. 
Mitral incompetence 
A malfunction of the mitral valve that permits the backflow of blood 
(regurgitation) from the left ventricle into the left atrium. 
Modifiable To change somewhat the form or qualities of; alter partially. 
Morbidity The rate of disease in a population. 
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The number of deaths in a given area or period, or from a particular 
cause. 
Myocardial cell 
The muscle cells (myocytes) that make up the cardiac muscle (heart 
muscle). 
Myocardial infarction 
Infarction of a segment of heart muscle, usually due to occlusion of a 
coronary artery. 
Myocarditis Inflammation of the heart muscle. 
Myoglobin 
A red protein containing haem, which carries and stores oxygen in 
muscle cells. It is structurally similar to a subunit of haemoglobin. 
N 
Term Definition 
National Heart, Lung, 
and Blood Institute 
(NHLBI) 
The third largest Institute of the National Institutes of Health, located 
in Bethesda, Maryland, United States. It is tasked with allocating 
about $3.0  billion in tax revenue per year (fiscal year 2015 estimate) 
to advancing the understanding of the following issues: development 
and progression of disease, diagnosis of disease, treatment of disease, 
disease prevention, reduction of health care disparities within the 
American population, and advancing the effectiveness of the US 
medical system. 
Necropsy Another term for autopsy. 
Nicotine 
A toxic colourless or yellowish oily liquid which is the chief active 
constituent of tobacco. It acts as a stimulant in small doses, but in 
larger amounts blocks the action of autonomic nerve and skeletal 
muscle cells. 
Non-communicable Not transmissible by direct contact. 
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Non-modifiable That cannot be modified. 
Non-obstructive Not causing or characterized by obstruction. 
Non-Q-wave 
myocardial infarction 
Evidence of infarction in the absence of abnormal Q waves in any 




A type of myocardial infarction causing cardiomyocyte necrosis and 
death by a rise in serum troponin levels. The ECG may be normal or 
there may be transient ST-segment elevation, persistent or transient 
ST-segment depression, T-wave inversion, flat T waves or pseudo-
normalization of T waves. 
Nutrient 
A substance that provides nourishment essential for the maintenance 
of life and for growth. 
O 
Term Definition 
Obesity The state of being grossly fat or overweight. 
Obstructive Causing a blockage or obstruction. 
Occlusion The blockage or closing of a blood vessel or hollow organ. 
Ostium An opening into a vessel or cavity of the body. 
Overweight Above a weight considered normal or desirable. 
Oxidative Relating to the process or result of oxidizing or being oxidized. 
Oxygen 
A colourless, odourless reactive gas, the chemical element of atomic 
number 8 and the life-supporting component of the air. 
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An invasive treatment for a stenosed (narrowed) coronary artery. A 
balloon-tipped catheter is passed through artery of the heart that has 
developed stenosis. The balloon is aligned with the stenosed section 
and then inflated to dilate the coronary artery and allow the blood to 




A minimally invasive surgical procedure for the treatment of 
coronary atherosclerosis. A balloon-tipped catheter is inserted 
percutaneously into the arterial circulation, advanced to the aortic 
root, and directed with a flexible guide wire to the site of coronary 
stenosis. Having been positioned within the narrowed arterial 
segment, the balloon is inflated so as to stretch the lumen, fracture the 
obstructing plaque, or both. 
Peripheral vascular 
disease 
A disease of blood vessels outside the heart. Peripheral vascular 
disease (PVD) affects the peripheral circulation, as opposed to the 
cardiac circulation. PVD comprises diseases of both peripheral 
arteries and peripheral veins. 
Physician 
A person qualified to practise medicine, especially one who 
specializes in diagnosis and medical treatment as distinct from 
surgery. 
Placebo 
An inert substance or treatment which is designed to have no 
therapeutic value. 
Plaques 
A small, distinct, typically raised patch or region on or within the 
body resulting from local damage or deposition of material, such as a 
fatty deposit on an artery wall in atherosclerosis or a site of localized 
damage of brain tissue in Alzheimer's disease. 
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A small colourless disc-shaped cell fragment without a nucleus, 
found in large numbers in blood and involved in clotting. 
Plausible Seeming reasonable or probable. 
Plummet Fall or drop straight down at high speed. 
Population All the inhabitants of a particular place. 
Predispose 
Make someone liable or inclined to a specified attitude, action, or 
condition. 
Pregnancy The condition or period of being pregnant. 
Preservative 
A substance used to preserve foodstuffs, wood, or other materials 
against decay. 
Pressure gradient 
The change in pressure measured across a given distance is called a 
"pressure gradient".  
Prevalence The fact or condition of being prevalent; commonness. 
Preventable Able to be prevented or avoided. 
Priority 
The fact or condition of being regarded or treated as more important 
than others. 
Processed 
Perform a series of mechanical or chemical operations on 
(something) in order to change or preserve it. 
Pro-fibrotic That promotes fibrosis. 
Pro-inflammatory 
A proinflammatory cytokine or more simply an inflammatory 
cytokine is a type of signalling molecule (a cytokine) that is excreted 
from immune cells like helper T cells (Th) and macrophages, and 
certain other cell types that promote inflammation. 
Prolonged Continuing for a long time or longer than usual; lengthy. 
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Any of a class of nitrogenous organic compounds which have large 
molecules composed of one or more long chains of amino acids and 
are an essential part of all living organisms, especially as structural 
components of body tissues such as muscle, hair, etc., and as enzymes 
and antibodies. 
Prothrombin 
A protein present in blood plasma which is converted into active 
thrombin during coagulation. 
Proximal Situated nearer to the centre of the body or the point of attachment. 
Publication 





The QRS complex is a name for the combination of three of the 
graphical deflections seen on a typical electrocardiogram (EKG or 
ECG). It is usually the central and most visually obvious part of the 
tracing. It corresponds to the depolarization of the right and left 
ventricles of the human heart. 
Quantify Express or measure the quantity of. 
R 
Term Definition 
Race A group or set of people or things with a common feature or features. 
Radial Relating to the radius bone in the skeleton. 
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Red blood cell 
(Erythrocyte) 
A red blood cell, which (in humans) is typically a biconcave disc 
without a nucleus. Erythrocytes contain the pigment haemoglobin, 
which imparts the red colour to blood, and transport oxygen and 
carbon dioxide to and from the tissues. 
Referral 
An act of referring someone or something for consultation, review, 
or further action. 
Remodelling Any process of reshaping or reorganizing. 
Research 
The systematic investigation into and study of materials and sources 
in order to establish facts and reach new conclusions. 
Resistance The refusal to accept or comply with something. 
Resource 
A stock or supply of money, materials, staff, and other assets that can 
be drawn on by a person or organization in order to function 
effectively. 
Retrospective 
Relating to or being a study (as of a disease) that starts with the 
present condition of a population of individuals and collects data 
about their past history to explain their present condition. 
Revascularization 




Active or inactive disease of the heart that results from rheumatic 
fever and that is characterized by reduced functional capacity of the 
heart caused by inflammatory changes in the myocardium or scarring 
of the valves. 
Rupture Break or burst suddenly. 
Rural 
In, relating to, or characteristic of the countryside rather than the 
town. 
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Scarcity The state of being scarce or in short supply; shortage. 
Sedentary Characterized by much sitting and little physical exercise. 
Shock 
An acute medical condition associated with a fall in blood pressure, 
caused by such events as loss of blood, severe burns, allergic reaction, 
or sudden emotional stress, and marked by cold, pallid skin, irregular 
breathing, rapid pulse, and dilated pupils. 
Shunt An alternative path for the passage of the blood or other body fluid. 
Sibling 
Each of two or more children or offspring having one or both parents 
in common: a brother or sister. 
Signalling pathway 
A set of chemical reactions in a cell that occurs when a molecule, 
such as a hormone, attaches to a receptor on the cell membrane. The 
pathway is actually a cascade of biochemical reactions inside the cell 
that eventually reach the target molecule or reaction. 
Slight Small in degree; inconsiderable. 
Smoking 
The action or habit of inhaling and exhaling the smoke of tobacco or 
a drug. 
Smooth muscle 
Muscle tissue in which the contractile fibrils are not highly ordered, 
occurring in the gut and other internal organs and not under voluntary 
control. 
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South Africa (SA) 
The southernmost country in Africa. It is bounded to the south by 
2,798 kilometres (1,739 miles) of coastline of Southern Africa 
stretching along the South Atlantic and Indian Oceans; to the north 
by the neighbouring countries of Namibia, Botswana, and Zimbabwe; 
and to the east and northeast by Mozambique and Eswatini 
(Swaziland); and it surrounds the enclaved country of Lesotho. South 
Africa is the largest country in Southern Africa and the 24th-largest 
country in the world by land area and, with over 58 million people, is 
also the world's 24th-most populous nation. 
Stable angina 
Angina induced by effort and relieved by rest. It does not increase in 
frequency or severity, and is predictable in nature. 
Stainless steel A form of steel containing chromium, resistant to tarnishing and rust. 
Statin 
A lipid-lowering drug used to treat primary hypercholesterolaemia – 
a condition in which the concentrations of lipoproteins in the blood 
plasma are raised, increasing the likelihood of affected individuals 
developing coronary heart disease. 
ST-depression /  
ST-elevation 
The ST segment is the flat, isoelectric section of the ECG between 
the end of the S wave (the J point) and the beginning of the T wave. 
It represents the interval between ventricular depolarization and 
repolarization. The most important cause of ST segment abnormality 
(elevation or depression) is myocardial ischemia or infarction. 
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Acute myocardial injury (heart attack) detected by abnormal cardiac 
biomarkers in the setting of evidence of acute myocardial ischemia 
and with detection of a rise and/or fall of cardiac Troponin values 
together with symptoms of myocardial ischemia, new ischemic ECG 
changes (new ST-segment elevations in 2 contiguous leads or new 
bundle branch blocks with ischemic repolarization patterns), 
development of pathological Q waves, or imaging evidence of new 
loss of viable myocardium or new regional wall motion abnormality 
in a pattern consistent with an ischemic aetiology. 
Stenosis The abnormal narrowing of a passage in the body. 
Stent 
A widely used device with metal surfaces that are sometimes coated 
with a drug to prevent restenosis. It is used to maintain luminal 
patency. 
Stroke 
A sudden disabling attack or loss of consciousness caused by an 
interruption in the flow of blood to the brain, especially through 
thrombosis. 
Subacute Between acute and chronic. 
Subsidize Support (an organization or activity) financially. 
Sympathetic 
Relating to or denoting the part of the autonomic nervous system 
consisting of nerves arising from ganglia near the middle part of the 
spinal cord, supplying the internal organs, blood vessels, and glands, 
and balancing the action of the parasympathetic nerves. 
Symptom 
A physical or mental feature which is regarded as indicating a 
condition of disease, particularly such a feature that is apparent to the 
patient. 
SYNTAX score 
An angiographic grading tool to determine the complexity of 
coronary artery disease. 
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Denoting the part of the circulatory system concerned with the 
transport of oxygen to and carbon dioxide from the body in general, 
especially as distinct from the pulmonary part concerned with the 
transport of oxygen from and carbon dioxide to the lungs. 
Systole 
The phase of the heartbeat when the heart muscle contracts and 




A rare, hard, blue-grey, lustrous transition metal that is highly 
corrosion-resistant. 
Tertiary Third in order or level. 
Testosterone 
A steroid hormone that stimulates development of male secondary 
sexual characteristics, produced mainly in the testes, but also in the 
ovaries and adrenal cortex. 
Thrombolysis 
The dissolution of a blood clot, especially as induced artificially by 
infusion of an enzyme into the blood. 
Thrombosis 
Local coagulation or clotting of the blood in a part of the circulatory 
system. 
Thrombus 
A blood clot formed in situ within the vascular system of the body 
and impeding blood flow. 
Tobacco 
A preparation of the nicotine-rich leaves of an American plant, which 
are cured by a process of drying and fermentation for smoking or 
chewing. 
Total cholesterol 
The total amount of cholesterol in the blood, which includes low-
density lipoprotein (LDL) cholesterol and high-density lipoprotein 
(HDL) cholesterol. 
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A built-up area with a name, defined boundaries, and local 
government, that is larger than a village and generally smaller than a 
city. 
Toxic Poisonous. 
Traditional Existing in or as part of a tradition; long-established. 
Treatment Medical care given to a patient for an illness or injury. 
Triglyceride 
An ester formed from glycerol and three fatty acid groups. 
Triglycerides are the main constituents of natural fats and oils. 
Triple vessel disease 
One or more lesions in each of the three major coronary arteries (left 






Formerly known as the United Nations Fund for Population 
Activities, is a UN organization whose work involves the 
improvement of reproductive health; including creation of national 




An academic hospital located in the Free State province of South 
Africa. 
Unstable angina 
Myocardial ischemia at rest or minimal exertion in the absence of 
cardiomyocyte necrosis (cardiac biomarkers are not increased). 
Urban In, relating to, or characteristic of a town or city. 
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Vasoconstriction The constriction of blood vessels, which increases blood pressure. 
Ventricle A hollow part or cavity in an organ. 
Ventriculogram 
A medical imaging test used to determine a patient's cardiac function 
in the right, or more typically, left ventricle. Cardiac 
ventriculography involves injecting contrast media into the heart's 
ventricle(s) to measure the volume of blood pumped. 
Village 
A group of houses and associated buildings, larger than a hamlet and 
smaller than a town, situated in a rural area. 
Vital Absolutely necessary; essential. 
W 
Term Definition 
Wealthy Having a great deal of money, resources, or assets; rich. 
Weight loss A decrease in body weight. 
Western 





A prospective cohort study of 936 clinically stable symptomatic 
women who underwent coronary angiography to evaluate symptoms 
and signs of ischemia. 
Workload The amount of work to be done by someone or something. 
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A specialized agency of the United Nations that is concerned with 
international public health. It was established on 7 April 1948, and is 
headquartered in Geneva, Switzerland. The WHO is a member of the 
United Nations Development Group. Its predecessor, the Health 
Organization, was an agency of the League of Nations. 
World Heart Federation 
(WHF) 
A nongovernmental organization based in Geneva, Switzerland in 
1971. In 1978 the International Society of Cardiology merged with 
the International Cardiology Federation (which had been founded in 
1970) to form the International Society and Federation of Cardiology. 
This body changed its name in 1998 to the World Heart Federation. 
Y 
Term Definition 
Years of life lost (YLL) 
An estimate of the average years a person would have lived if he or 
she had not died prematurely. It is, therefore, a measure of premature 
mortality. As an alternative to death rates, it is a method that gives 
more weight to deaths that occur among younger people. 
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